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INTRODUCTION 
1.1 Microencapsulation: 
1, 2
 
Microencapsulation is one of the quality preservation techniques of sensitive 
substances and a method for production of materials with new valuable properties. 
Microencapsulation is process of enclosing micron sized particles in a polymeric shell. There 
are different techniques available for the encapsulation of drug entities. The encapsulation 
efficiency of the micro particle or microsphere or microcapsule depends upon different 
factors like concentration of the polymer, solubility of polymer in solvent, rate of solvent 
removal, solubility of organic solvent in water etc. 
Microencapsulation is described as a process of enclosing micron sized particles of 
solids or droplets of liquids or gasses in an inert shell, which in turn isolates and protects 
them from the external environment. The product obtained by this process is called as 
microparticles, microcapsules, microspheres which differentiate in morphology and internal 
structure. When the particle size is below 1µm are known as nanoparticles, Nano capsules, 
Nano spheres respectively
 
and particles having diameter between 3 – 800 µm are known as 
microparticles or microcapsules or microspheres. Particles larger than 1000 µm are known as 
macro particles. 
 Microparticles or microcapsules consist of two components namely core material and 
coat or shell material. Core material contains active ingredient while coat or shell material 
covers or protects the core material. Different types of materials like active pharmaceutical 
ingredients, proteins, peptides, volatile oils, food materials, pigments, dyes, monomers, 
catalysts, pesticides etc.  Can be encapsulated with different types of coat or shell materials 
like ethyl cellulose, hydroxyl propyl methyl cellulose, sodium carboxy methyl cellulose, 
sodium alginate, PLGA, gelatin, polyesters, chitosans etc. 
1.2 Ideal characteristics of microspheres: 
 The ability to incorporate reasonably high concentrations of the drug. 
 Stability of the preparation after synthesis with a clinically acceptable shelf life. 
 Controlled particle size and dispersability in aqueous vehicles for injection. 
 Release of active reagent with a good control over a wide timescale. 
 Biocompatibility with a controllable biodegradability. 
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1.3 Microencapsulation technique: 
There are various techniques are available for the encapsulation of core materials. 
Broadly the methods are divided into two types. 
1. Chemical methods  
2. Physico-chemical methods  
3. Physico-mechanical methods 
                      
Table No.1: Different techniques used for microencapsulation
 
 
Chemical processes 
 
Physico - chemical 
processes 
 
Physico - Mechanical 
process 
 Interfacial 
polymerization 
 In situ 
polymerization 
 Poly condensation 
 Coacervation and 
phase separation 
 Sol-gel 
encapsulation 
 Supercritical CO2 
assisted 
microencapsulation 
 Spray drying and 
congealing 
 Fluid bed coating 
 Pan coating 
 Solvent evaporation 
  
 Fluidized bed or air suspension method, coacervation and phase separation, spray 
drying and spray congealing, pan coating, solvent evaporation methods are widely used. 
Depending on the physical nature of the core substance to be encapsulated the technique used 
will be varied. 
. 
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Table No.2: Microencapsulation and their applicability’s 
 
Microencapsulation process 
 
Nature of the Core material 
 
Approximate particle size 
(µm) 
 Air suspension 
 Coacervation and 
phase separation 
 Multi orifice 
centrifugation 
 Pan coating 
 Spray drying and 
congealing 
 Solvent evaporation 
 Solids 
 Solids and Liquids 
 
 Solids and Liquids 
 Solids 
 Solids and Liquids 
 Solids and Liquids 
 
35-5000
*
 
2-5000
*
 
 
1-5000
*
 
600-5000
* 
600 
5-5000
*
 
 
*
The 5000µm size is not a particle size limitation. The Methods are also applicable for macro 
coating 
 
1.4 Chemical methods: 
a) Interfacial polymerization ( IFP) :  
In this technique the capsule shell will be formed at or on the surface of the droplet or 
particle by polymerization of the reactive monomers. The substances used are multifunctional 
monomers. Generally used monomers include multifunctional isocyanates and 
multifunctional acid chlorides. These will be used either individually or in combination. The 
multifunctional monomer dissolved in liquid core material and it will be dispersed in aqueous 
phase containing dispersing agent. A coreactant multifunctional amine will be added to the 
mixture. This results in rapid polymerization at interface and generation of capsules hell takes 
place
.
 A polyurea shell will be formed when isocyanate reacts with amine, polynylon or 
polyamide shell will be formed when acid chloride reacts with amine. When isocyanate reacts 
with hydroxyl containing monomer produces polyurethane shell.   
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b) In-situ polymerization:  
Like IFP the capsule shell formation occurs because of polymerization monomers 
added to the encapsulation reactor. In this process no reactive agents are added to the core 
material, polymerization occurs exclusively in the continuous phase and on the continuous 
phase side of the interface formed by the dispersed core material and continuous phase. 
Initially a low molecular weight prepolymer will be formed, as time goes on the prepolymer 
grows in size, it deposits on the surface of the dispersed core material there by generating 
solid capsule shell. E.g. encapsulation of various water immiscible liquids with shells formed 
by the reaction at acidic pH of urea with formaldehyde in aqueous media. Wang Qiangbin 
prepared Carboxyl-functionalized magnetic microspheres by in situ polymerization of styrene 
and methyacrylic acid at 85°C in the presence of nano-Fe3O4 in styrene, using lauryl peroxide 
as an initiator. 
1.5 Physico-chemical methods: 
a) Coacervation and phase separation:  
It is defined as partial desolvation of a homogeneous polymer solution into a polymer-rich 
phase (coacervate) and the poor polymer phase (coacervation medium). The term originated 
from the Latin “acervus” meaning “heap”. This was the first reported process to be adapted 
for the industrial production of microcapsules. Currently, two methods for coacervation are 
available, namely simple and complex processes. The mechanism of microcapsule formation 
for both processes is identical, except for the way in which the phase separation is carried out. 
In simple coacervation a desolvation agent is added for phase separation, whereas complex 
coacervation involves complexation between two oppositely charged polymers. The three 
basic steps in complex coacervation are:  
(i) formation of three immiscible phases;  
(ii) deposition of the coating; and  
(iii) Rigidization of the coating. 
First step include formation of three immiscible phases; liquid manufacturing vehicle, 
core material, coating material. The core material is dispersed in a solution of the coating 
polymer. The coating material phase, an immiscible polymer in liquid state is formed by  
(i) changing temperature of polymer solution, e.g. ethyl cellulose in cyclohexane (N-
acetyl P-amino phenol as core), 
(ii) addition of salt, e.g. addition of sodium sulphate solution to gelatine solution in 
vitamin encapsulation 
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(iii) addition of nonsolvent, e.g. addition of isopropyl ether to methyl ethyl ketone 
solution of cellulose acetate butyrate (methylscopalamine hydrobromide is core), 
(iv) addition of incompatible polymer to the polymer solution, e.g. addition of 
polybutadiene to the solution of ethyl cellulose in toluene (methylene blue as core 
material), 
(v) Inducing polymer – polymer interaction, e.g. interaction of gum Arabic and gelatin 
at their iso-electric point Second step, includes deposition of liquid polymer upon 
the core material. Finally, the prepared microcapsules are stabilized by 
crosslinking, desolvation or thermal treatment. 
Crosslinking is the formation of chemical links between molecular chains to form a 
three-dimensional network of connected molecules. The vulcanization of rubber using 
elemental sulfur is an example of crosslinking, converting raw rubber from a weak plastic to 
a highly resilient elastomer. The strategy of covalent crosslinking is used in several other 
technologies of commercial and scientific interest to control and enhance the properties of the 
resulting polymer system or interface, such as thermosets and coatings. Crosslinking has been 
employed in the synthesis of ion-exchange resins and stimuli-responsive hydrogelsmade from 
polymer molecules containing polar groups. As polyelectrolytes, hydrogels are inherently 
water soluble. To make them insoluble, they are chemically cross linked during manufacture 
or by a second reaction following that of polymerization of the starting monomers. The 
degree of crosslinking, quantified in terms of the crosslink density, together with the details 
of the molecular structure, have a profound impact on the swelling characteristics of the cross 
linked system. E.g. Derivatives of ethylene glycol di(meth)acrylate like, Ethylene glycol 
acrylate, Di(ethylene glycol) diacrylate, Tetra(ethylene glycol) diacrylate, Ethylene glycol 
dimethacrylate, Di(ethylene glycol) dimethacrylate, Tri(ethylene glycol) dimethacrylate; 
Derivatives of methylenebisacrylamide like N,N.- Methylenebisacrylamide, N,N.-
Methylenebisacrylamide, N,N.- (1,2- Dihydroxyethylene) bisacrylamide, glutaraldehyde, 
sodium tripolyphosphate etc. 
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                                                          Fig. 1:  Coacervation process.  
(a) Core material dispersion in solution of shell polymer; (b) separation of coacervate 
from solution; (c) coating of core material by microdroplets of coacervate; (d) 
coalescence of coacervate to form continuous shell around core particles. 
Xiangchun Yin prepared microspheres by Poly (styrene-alt-maleic anhydride) 
partially grafted with methoxy poly (ethylene glycol) (SMA-g-MPEG) was prepared by 
reacting poly (styrene-alt-maleic anhydride) with a sub stoichiometric amount of MPEG 
lithium alcoholate. Aqueous solutions of the resulting SMA-g-MPEG formed complex 
coacervates with poly (di allyl di methyl ammonium chloride) (PDADMAC). These phase-
separated liquid polyelectrolyte complexes were subsequently cross-linked by the addition of 
two different polyamines to prepare cross-linked hydrogel microspheres. Chitosan served as 
an effective cross-linker at pH 7.0, while poly ethylenimine (PEI) was used as cross-linker 
under basic conditions (pH 10.5). The resulting coacervate microspheres swelled with 
increasing salinity, which was attributed mainly due to the shielding of the electrostatic 
association within the polyelectrolyte complex. 
Ya-I Huang, prepared microcapsules by using gelatin and gum Arabic by 
coacervation. The most frequently used crosslinking agent formaldehyde in the gelatin–
acacia microencapsulation process was altered by glycerol in this formulation. They found 
that the yield of gelatin–acacia microcapsules decreases at surfactant concentrations above or 
below the optimum. Inhibition of coacervation due to high concentrations of surfactants and 
disturbance of microencapsulation due to high hydrophilic–lipophilic balance (HLB) values 
have been reported. In general, the concentration of a surfactant required to increase the yield 
of microcapsules is too low to produce regular-sized droplets. The analysis of the size 
distribution shows that the microcapsules are multi-dispersed. 
 In the coacervation process, the pH value of a continuous gelatin phase would be 
adjusted above its isoelectric point to form negatively charged gelatin, which is able to create 
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monodispersed droplets. The positively charged gelatin is attracted to the negatively charged 
acacia to form coacervate droplets when the pH value is adjusted to below its isoelectric 
point. Therefore, the particle size distributions of emulsion droplets are effected by the 
factors of pH adjustment, especially the adding rate of the acidifying agent.  
The report shows the indomethacin microcapsules had the slowest release rate when 
the coacervation pH was adjusted to the electrical equivalence pH value and not to the pH of 
maximum coacervate yield. Gelatin is only stable at the pH value between 4 and 6, data 
shown that the alkalization caused the breaking of the wall of the microcapsule made by the 
crosslinking agent of glycerol. Not only is the purple-colored shikonin alkalized into a blue 
color, but the saponification effects may also be undergone by the solvent (sesame oil) of 
extract containing shikonin reacting with sodium hydride. 
 However, this reaction would not be shown in the microcapsule made by the 
crosslinking agent of formaldehyde. This explains why the shell of the microcapsule made by 
formaldehyde is more rigid than that made by glycerol. In other words, the microcapsule 
made by glycerol has a more permeable shell than made by formaldehyde. The particle size 
of the microcapsule was not affected by the difference of crosslinking agents. Using the low 
concentration 3% and 6% of plasticizer glycerol instead of formaldehyde, similar 
morphology results were obtained. Increasing the amount of crosslinking agent leads to an 
increase in the encapsulation ability. However, the results indicated that above 6% of 
glycerin, encapsulation ability decreases as the crosslinking agent increases due to the 
alteration of the mechanism and inability to integrate into the network even after the addition 
of an excess amount. 
b) Polymer Encapsulation by Rapid Expansion of Supercritical Fluids: 
Supercritical fluids are highly compressed gasses that possess several advantageous 
properties of both liquids and gases. The most widely used being supercritical CO2, alkanes 
(C2 to C4) and nitrous oxide (N2O). A small change in temperature or pressure causes a large 
change in the density of supercritical fluids near the critical point. Supercritical CO2 is widely 
used for its low critical temperature value, in addition to its nontoxic, non-flammable 
properties; it is also readily available, highly pure and cost-effective.  
 
The most widely used methods are as follows: 
• Rapid expansion of supercritical solution (RESS) 
• Gas anti-solvent (GAS) 
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• Particles from gas-saturated solution (PGSS) 
i) Rapid expansion of supercritical solution: 
Supercritical fluid containing the active ingredient and the shell material are 
maintained at high pressure and then released at atmospheric pressure through a small nozzle. 
The sudden drop in pressure causes desolvation of the shell material, which is then deposited 
around the active ingredient (core) and forms a coating layer. The disadvantage of this 
process is that both the active ingredient and the shell material must be very soluble in 
supercritical fluids. In general, very few polymers with low cohesive energy densities (e.g., 
poly di methyl siloxanes, poly methacrylates) are soluble in supercritical fluids such as CO2. 
The solubility of polymers can be enhanced by using co-solvents. In some cases non solvents 
are used; this increases the solubility in supercritical fluids, but the shell materials do not 
dissolve at atmospheric pressure. Kiyoshi et al. had very recently carried out 
microencapsulation of TiO2 nanoparticles with polymer by RESS using ethanol as a non-
solvent for the polymer shell such as polyethylene glycol, poly(styrene)-b-(poly(methyl 
methacrylate)-copoly (glycidal methacrylate) copolymer (PS-b-(PMMA-co-PGMA) and 
poly(methyl methacrylate)  
 
         Fig. 2: Microencapsulation by rapid expansion of supercritical 
solutions (RESS) 
ii) Gas anti-solvent (GAS) process: 
This process is also called supercritical fluid anti-solvent (SAS). Here, supercritical 
fluid is added to a solution of shell material and the active ingredients and maintained at high 
pressure. This leads to a volume expansion of the solution that causes super saturation such 
that precipitation of the solute occurs. Thus, the solute must be soluble in the liquid solvent, 
but should not dissolve in the mixture of solvent and supercritical fluid. On the other hand, 
the liquid solvent must be miscible with the supercritical fluid. This process is unsuitable for 
the encapsulation of water-soluble ingredients as water has low solubility in supercritical 
fluids. It is also possible to produce submicron particles using this method. 
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iii) Particles from a gas-saturated solution (PGSS): 
This process is carried out by mixing core and shell materials in supercritical fluid at 
high pressure. During this process supercritical fluid penetrates the shell material, causing 
swelling. When the mixture is heated above the glass transition temperature (Tg), the 
polymer liquefies. Upon releasing the pressure, the shell material is allowed to deposit onto 
the active ingredient. In this process, the core and shell materials may not be soluble in the 
supercritical fluid. 
1.6 Physico-Mechanical process: 
a) Spray drying and congealing :  
Microencapsulation by spray-drying is a low-cost commercial process which is mostly 
used for the encapsulation of fragrances, oils and flavors. Core particles are dispersed in a 
polymer solution and sprayed into a hot chamber. The shell material solidifies onto the core 
particles as the solvent evaporates such that the microcapsules obtained are of polynuclear or 
matrix type. Chitosan microspheres cross-linked with three different cross-linking agents viz, 
tri poly phosphate (TPP), formaldehyde (FA) and gluteraldehyde (GA) have been prepared 
by spray drying technique. The influence of these cross-linking agents on the properties of 
spray dried chitosan microspheres was extensively investigated.  
The particle size and encapsulation efficiencies of thus prepared chitosan microspheres 
ranged mainly between 4.1–4.7µm and 95.12–99.17%, respectively. Surface morphology, % 
erosion, % water uptake and drug release properties of the spray dried chitosan microspheres 
was remarkably influenced by the type (chemical or ionic) and extent (1 or 2%w/w) of cross-
linking agents. Spray dried chitosan microspheres cross-linked with TPP exhibited higher 
swelling capacity, % water uptake, % erosion and drug release rate at both the cross-linking 
extent (1 and 2%w/w) when compared to those cross-linked with FA and GA. The sphericity 
and surface smoothness of the spray dried chitosan microspheres was lost when the cross-
linking extent was increased from 1 to 2%w/w. Release rate of the drug from spray dried 
chitosan microspheres decreased when the cross-linking extent was increased from 1 to 2% 
w/w. The physical state of the drug in chitosan-TPP, chitosan-FA and chitosan-GA matrices 
was confirmed by the X-ray diffraction (XRD) study and found that the drug remains in a 
crystalline state even after its encapsulation. Release of the drug from chitosan-TPP, 
chitosan-FA and chitosan-GA matrices followed Fick's law of diffusion. 
Spray congealing can be done by spray drying equipment where protective coating will 
be applied as a melt. Core material is dispersed in a coating material melt rather than a 
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coating solution. Coating solidification is accomplished by spraying the hot mixture into cool 
air stream. Waxes, fatty acids, and alcohols, polymers which are solids at room temperature 
but mutable at reasonable temperature are applicable to spray congealing. Albertini B 
prepared mucoadhesive microparticles and to designed innovative vaginal delivery systems 
for econazole nitrate (ECN) to enhance the drug antifungal activity. Seven different 
formulations were prepared by spray-congealing, a lipid-hydrophilic matrix was used as 
carrier and several mucoadhesive polymers such as chitosan, sodium carboxymethylcellulose 
and poloxamers were added. 
 
.  
                                        Fig. 3: Micro-encapsulation by spray-drying 
 
b) Fluidized-Bed Technology: 
The liquid coating is sprayed onto the particles and the rapid evaporation helps in the 
formation of an outer layer on the particles. The thickness and formulations of the coating can 
be obtained as desired. Different types of fluid-bed coaters include top spray, bottom spray, 
and tangential spray. 
In the top spray system the coating material is sprayed downwards on to the fluid bed 
such that as the solid or porous particles move to the coating region they become 
encapsulated. Increased encapsulation efficiency and the prevention of cluster formation are 
achieved by opposing f lows of the coating materials and the particles. Dripping of the coated 
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particles depends on the formulation of the coating material. Top spray fluid-bed coaters 
produce higher yields of encapsulated particles than either bottom or tangential sprays. 
 The bottom spray is also known as “Wurster‟s coater” in recognition of its development 
by Prof. D.E. Wurster This technique uses a coating chamber that has a cylindrical nozzle and 
a perforated bottom plate. The cylindrical nozzle is used for spraying the coating material. As 
the particles move upwards through the perforated bottom plate and pass the nozzle area, they 
are encapsulated by the coating material. The coating material adheres to the particle surface 
by evaporation of the solvent or cooling of the encapsulated particle. This process is 
continued until the desired thickness and weight is obtained. Although it is a time consuming 
process, the multilayer coating procedure helps in reducing particle defects. 
The tangential spray consists of a rotating disc at the bottom of the coating chamber, with 
the same diameter as the chamber. During the process the disc is raised to create a gap 
between the edge of the chamber and the disc. The tangential nozzle is placed above the 
rotating disc through which the coating material is released. The particles move through the 
gap into the spraying zone and are encapsulated. As they travel a minimum distance there is a 
higher yield of encapsulated particles. 
 
                                             Fig. 4: Schematics of a fluid-bed coater.  
                                (a) Top spray; (b) bottom spray; (c) tangential spray 
c) Solvent evaporation:  
 The coating material is dissolved in a volatile solvent, which is immiscible with the 
liquid manufacturing vehicle phase. A core material to be encapsulated to be dissolved or 
dispersed in the coating polymer solution. This mixture is added to the liquid manufacturing 
vehicle phase with agitation, the mixture is heated to evaporate the solvent for polymer. Here 
the coat material shrinks around the core material and encapsulate the core. Microspheres of 
5-fluorouracil have been prepared, using three grades of ethyl cellulose as wall forming 
materials, and utilizing a solvent evaporation technique under ambient conditions. An 
alcoholic solution of 5-fluorouracil and polymer was dispersed in liquid paraffin containing 
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33.3 per cent n-heptane. The effect of stirring rate, time of stirring, drug loading, and polymer 
grade on drug release in two different media was evaluated. The drug loaded particles were 
spherical in shape and had a diameter range of 25-200 mm and were suitable for 
incorporating into a gel base. Drug release studies in aqueous media, showed that acidic 
media provide a faster release rate than neutral media. The drug release study from an 
aqueous gel base preparation at pH 7.0 through a synthetic membrane was found to be 
promising for formulation of a gel-microsphere product for the treatment of skin lesions. 
Pseudoephedrine HCl, a highly water-soluble drug, was entrapped within poly (methyl 
methacrylate) microspheres by a water/oil/water emulsification-solvent evaporation method. 
An aqueous drug solution was emulsified into a solution of the polymer in methylene 
chloride, followed by emulsification of this primary emulsion into an external aqueous phase 
to form a water/oil/water emulsion. The middle organic phase separated the internal drug-
containing aqueous phase from the continuous phase. Microspheres were formed after solvent 
evaporation and polymer precipitation. The drug content of the microspheres increased with 
increasing theoretical drug loading, increasing amounts of organic solvent, polymer and 
polymeric stabilizer, and decreased with increasing stirring time, increasing pH of the 
continuous phase and increased volume of the internal and external aqueous phase. 
c) Pan coating: 
The coating solution is applied as atomized spray to the solid core material in the coating 
pan. To remove the coating solvent warm air is passed over the coated material. By using this 
technique larger sized particles will be coated effectively.  
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1.7 FACTORS INFLUENCING ENCAPSULATION EFFICIENCY: 
The encapsulation efficiency of the microparticle or microcapsule or microsphere will 
be affected by different parameters.  . 
 
 Solubility of polymer in the organic solvent: 
The effect of solubilities of the polymers of different PLGAs in methylene chloride was 
compared by measuring the methanol cloud point (Cs): Higher Cs meant that the polymer 
was more soluble in methylene chloride and, thus, required a greater amount of methanol to 
precipitate from the polymer solution. The PLGA polymer of a relatively high L/G ratio 
(75/25) had a higher solubility in methylene chloride than the other PLGA (L/G ratio=50/50). 
A lower molecular weight polymer had a higher solubility in methylene chloride than a 
higher molecular weight polymer. End-capped polymers, which were more hydrophobic than 
non-end-capped polymers of the same molecular weight and component ratio, were more 
soluble in methylene chloride. 
Diffusion of drugs into the continuous phase mostly occurred during the first 10 minutes 
of emulsification; therefore, as the time the polymer phase stayed in the non-solidified (semi-
solid) state was extended, encapsulation efficiency became relatively low. In Mehta‟s study, 
polymers having relatively high solubility in methylene chloride took longer to solidify and 
resulted in low encapsulation efficiencies, and vice versa. Particle size and bulk density also 
varied according to the polymer. Since polymers having higher solubilities in methylene 
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chloride stayed longer in the semi-solid state, the dispersed phase became more concentrated 
before it completely solidified, resulting in denser micro particles. 
The use of relatively hydrophilic PLGA which carried free carboxylic end groups resulted 
in significantly higher encapsulation efficiency compared to that of an end-capped polymer.  
A similar explanation as above applies to this observation: Hydrophilic PLGA is relatively 
less soluble in the solvent, methylene chloride, and precipitates more quickly than the end-
capped one. High solidification rate might have increased the encapsulation efficiency. On 
the other hand, the authors attribute the increase to the enhanced interaction between PLGA 
and the protein through hydrogen bonding and polar interactions. Walter. Also observed an 
increased encapsulation efficiency from using relatively hydrophilic PLGA in DNA micro 
encapsulation. The hydrophilicity of the polymer enhanced the stability of the primary 
emulsion, and it contributed to such an increase was due to the slow solidification of the 
microparticles.  
 Solubility of organic solvent in water: 
Methylene chloride resulted in higher encapsulation efficiency as compared with 
chloroform or benzene, even though methylene chloride was a better solvent for poly (lactic 
acid) (PLA) than the others. Methylene chloride is more soluble in water than chloroform or 
benzene. The „high‟ solubility allowed relatively fast mass-transfer between the dispersed and 
the continuous phases and led to fast precipitation of the polymer. The significance of 
solubility of the organic solvent in water was also confirmed by the fact that the addition of 
water-miscible co-solvents such as acetone, methanol, ethyl acetate, or dimethyl sulfoxide 
(DMSO), contributed to increase of the encapsulation efficiency. Knowing that the methanol 
is a non-solvent for PLA and a water-miscible solvent, it can be assumed that methanol 
played a dual function in facilitating the polymer precipitation: First, the presence of 
methanol in the dispersed phase decreased the polymer solubility in the dispersed phase. 
Second, as a water-miscible solvent, methanol facilitated diffusion of water into the dispersed 
phase. 
The low encapsulation efficiency of benzene is explained such that benzene required a 
larger amount of water (non-solvent) than methylene chloride for precipitation of the 
polymer, and the drug was lost due to the delayed solidification. However, given that benzene 
is a poorer solvent than methylene chloride for a PLA polymer, this argument does not agree 
with the widely spread idea that a poor solvent requires a smaller amount of non-solvent to 
precipitate a polymer. In fact, there could have been a better explanation if they had 
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considered that the delayed solidification was due to the low solubility of benzene in water: 
As a poor solvent for a PLA polymer, benzene requires only a small amount of non-solvent 
for complete solidification of the polymer. However, since benzene can dissolve only a tiny 
fraction of water, it takes much longer to uptake water into the dispersed phase. That is, while 
solubility of a polymer in an organic solvent governs the quantity of a nonsolvent required in 
precipitating a polymer, solubility of the organic solvent in the non-solvent limits diffusion of 
the non-solvent into the polymer phase. Thus, when a cosolvent system is involved, both 
solubility of a polymer in a solvent and solubility of the solvent in a non-solvent participate in 
determining the solidification rate of the dispersed phase. 
 Lysozyme-loaded PLGA microparticles were prepared using the oil in water (o/w) single 
emulsion technique. Here, the authors used a co-solvent system, varying the ratio of the 
component solvents. DMSO was used for solubilization of lysozyme and PLGA, and 
methylene chloride was used for generation of emulsion drops as well as solubilization of 
PLGA. Encapsulation efficiency increased, and initial burst decreased as the volume fraction 
of DMSO in the co-solvent system increased. Particle size increased, and density of the 
microparticle matrix decreased with increasing DMSO. Overall, these results indicate that the 
presence of DMSO increased the hydrophilicity of the solvent system and allowed fast 
extraction of the solvent into the continuous phase, which led to higher encapsulation 
efficiency and larger particle size. 
 Concentration of the polymer: 
Encapsulation efficiency increases with increasing polymer concentration. For example, 
the encapsulation efficiency increased from 53.1 to 70.9% when concentration of the polymer 
increased from 20.0 to 32.5% (Mehta et al. High viscosity and fast solidification of the 
dispersed phase contributed to reducing porosity of the micro particles as well. The 
contribution of a high polymer concentration to the encapsulation efficiency can be 
interpreted in two ways. First, when highly concentrated, the polymer precipitates faster on 
the surface of the dispersed phase and prevents drug diffusion across the phase boundary. The 
high concentration increases viscosity of the solution and delays the drug diffusion within the 
polymer droplets. 
Encapsulation efficiency and particle size increase as the volume of the continuous phase 
increases. For example, the encapsulation efficiency increased more than twice as the ratio of 
the dispersed phase to the continuous phase (DP/CP ratio) decreased from 1/50 to 1/300. It is 
likely that a large volume of continuous phase provides a high concentration gradient of the 
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organic solvent across the phase boundary by diluting the solvent, leading to fast 
solidification of the microparticles. 
 A relevant observation is described in the literature (Sah,. In this example, which utilized 
ethyl acetate as a solvent, the formation of microparticles was dependent on the volume of the 
continuous phase. When 8 mL of PLGA solution (o) was poured into 20 or 50 mL of water 
phase (w), the polymer solution was well disintegrated into dispersed droplets. On the other 
hand, when the continuous phase was 80 mL or more, the microspheres hardened quickly and 
formed irregular precipitates. This is because the large volume of continuous phase provided 
nearly a sink condition for ethyl acetate and extracted the solvent instantly. Due to the fast 
solidification of the polymer, particle size increased with increasing volume of the continuous 
phase. Microparticles generated from a low DP/CP ratio had a lower bulk density (0.561 g/cc 
at 1/50 vs. 0.357 g/cc at 1/ 300), which the authors interpret as an indication of higher 
porosity of the polymer matrix (Mehta et al., On the other hand, a different example shows 
that a higher DP/ CP ratio resulted in increased porosity, providing a large specific surface 
area (measured by the BET method) and the scanning electron microscope (SEM) pictures as 
evidence . 
This apparent discrepancy can be explained by the fact that low bulk density (Mehta et 
al., is not a true reflection of porosity but a result of large particle size. In fact, porosity 
increases with increasing DP/CP ratio, i.e., decreasing rate of the polymer precipitation.  
 Rate of solvent removal: 
The method and rate of solvent removal influence the solidification rate of the dispersed 
phase as well as morphology of the resulting microparticles. In the emulsion-solvent 
evaporation or extraction method, the solvent can be removed by  
(i) Evaporation, in which the solvent is evaporated around its boiling point or  
(ii) Extraction into the continuous phase.  
The rate of solvent removal can be controlled by the temperature ramp or the evaporation 
temperature in the former and by the volume of the dilution medium in the latter. PLGA 
microparticles containing salmon calcitonin (SCT) were prepared by emulsification, 
followed by different solvent removal processes. In the temperature dependent solvent 
removal process, the solvent (methylene chloride) was removed by increasing the 
temperature from 15 to 40
o
C at different rates. The microparticles that resulted from this 
process had a hollow core and a porous wall.  
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The core size and wall thickness were dependent on the temperature ramp. A rapid rise in 
temperature resulted in a thin wall and a large hollow core, whereas a stepwise temperature 
rise (15 to 25, then to 40
o
C) resulted in a reduced core size. It is believed that the hollow 
core was due to the rapid expansion of methylene chloride chloride entrapped within the 
solidified microparticles. In controlled extraction of the solvent, the solvent was removed 
gradually and slowly by dilution of the continuous phase, which left the microparticles in 
the soft state for a longer period of time.  
The resulting microparticles showed a highly porous honeycomb- like internal structure 
without a hollow core. In the later study, it was noted that the porosity was a function of the 
amount of water diffused into the dispersed phase from the continuous phase, which could 
only be allowed before the dispersed phase solidified completely .In other words, the high 
porosity of the microparticles that fast polymer solidification results in high encapsulation 
efficiency, this does not apply to the observation of Yang et al.. Here, the encapsulation 
efficiency was not affected by the solvent evaporation temperature. It may be due to the 
different processing temperatures influenced not only the rate of polymer solidification but 
also the diffusivity of the protein and its solubility in water. While the high temperature 
facilitated solidification of the dispersed phase, it enhanced diffusion of the protein into the 
continuous phase, compromising the positive effect from the fast solidification. 
 Interaction between drug and polymer: 
Interaction between protein and polymer contributes to increasing encapsulation 
efficiency. Generally, proteins are capable of ionic interactions and are better encapsulated 
within polymers that carry free carboxylic end groups than the end-capped polymers. On the 
other hand, if hydrophobic interaction is a dominant force between the protein and the 
polymer, relatively hydrophobic end-capped polymers are more advantageous in increasing 
encapsulation efficiency. For example, encapsulation efficiencies of more than 60% were 
achieved for salmon calcitonin (SCT) microparticles despite the high solubility of SCT in the 
continuous phase.  This is attributed to the strong affinity of SCT to hydrophobic polymers 
such as PLGA. On the other hand, such interactions between protein and polymer can limit 
protein release from the microparticles. In certain cases, a co-encapsulated excipient can 
mediate the interaction between protein and polymer.  
Encapsulation efficiency increased when gamma hydroxyl propyl cyclo sdextrin (g-
HPCD) were co-encapsulated with tetanus toxoid in PLGA microparticles. It is supposed that 
the g-HPCD increased the interaction by accommodating amino acid side groups of the 
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toxoid into its cavity and simultaneously interacting with PLGA through van der Waals and 
hydrogen bonding forces. 
 Solubility of drug in continuous phase: 
Drug loss into the continuous phase occurs while the dispersed phase stays in a 
transitional, semi-solid state. If the solubility of the drug in the continuous phase is higher 
than in the dispersed phase, the drug will easily diffuse into the continuous phase during this 
stage. For example, the encapsulation efficiency of quinidine sulfate was 40 times higher in 
the alkaline continuous phase (pH 12, in which quinidine sulfate is insoluble) than in the 
neutral continuous phase (pH 7, in which quinidine sulfate is very soluble) 
 
 Molecular weight of the polymer: 
The effect of molecular weight of the polymer on encapsulation efficiency developed a 
long-acting injectable huperzine A-PLGA microsphere for the chronic therapy of Alzheimer's 
disease, the microsphere was prepared by using o/w emulsion solvent extraction evaporation 
method.  The morphology of the microspheres was observed by scanning electron 
microscopy. The distribution of the drug within microspheres was observed by a confocal 
laser scanning microscope.  
The results indicated that the PLGA 15000 microspheres possessed a smooth and round 
appearance with average particle size of 50 µm or so. The encapsulation percentages of 
microspheres prepared from PLGA 15 000, 20 000 and 30 000 were 62.75, 27.52 and 
16.63%, respectively. The drug release percentage during the first day decreased from 
22.52% of PLGA 30 000 microspheres to 3.97% of PLGA 15a000 microspheres, the 
complete release could be prolonged to 3 weeks. The initial burst release of microspheres 
with higher molecular weight PLGA could be explained by the inhomogeneous distribution 
of drug within microspheres. The encapsulation efficiency of the microspheres improved as 
the polymer concentration increase in oil phase and PVA concentration decreased in aqueous 
phase. The burst release could be controlled by reducing the polymer concentration. 
Evaporation temperature had a large effect on the drug release profiles. It had better be 
controlled under 30°C. Within a certain range of particle size, encapsulation efficiency 
decreased and drug release rate increased with the reducing of the particle size. 
1.8 Applications: 
The technology has been used widely in the design of controlled release and sustained 
release dosage forms. 
 To mask the bitter taste of drugs like Paracetamol, Nitrofurantoinetc. 
INTRODUCTION 
 
Department of Pharmaceutics, Nandha College of Pharmacy, Erode Page 19 
 
 To reduce gastric and other G.I. tract irritations.  
 Sustained release Aspirin preparations have been reported to cause significantly less 
G.I. bleeding than conventional preparations. 
 A liquid can be converted to a pseudo-solid for easy handling and storage. 
eg.Eprazinone. 
 Hygroscopic properties of core materials may be reduced by microencapsulation eg. 
Sodium chloride. 
 Carbon tetra chlorides and a number of other substances have been microencapsulated 
to reduce their odor and volatility. 
 Microencapsulation has been employed to provide protection to the core materials 
against atmospheric effects, e.g. Vit-A, Palmitate. 
1.9 Advantages: 
 Reliable means to deliver the drug to the target site with specificity, if modified, and 
to maintain the desired concentration at the site of interest without untoward effects. 
 Solid biodegradable microspheres have the potential throughout the particle matrix for 
the controlled release of drug. 
 Microspheres received much attention not only for prolonged release, but also for 
targeting of anticancer drugs to the tumour. 
 The size, surface charge and surface hydrophillicity of microspheres have been found 
to be important in determining the fate of particles in vivo. 
1.10 Floating systems:
 3, 4, 5. 6. 7 
These have a bulk density lower than the gastric content. They remain buoyant in the stomach 
for a prolonged period of time, with the potential for continuous release of drug. Eventually, 
the residual system is emptied from the stomach. Gastric emptying is much more rapid in the 
fasting state and floating systems rely heavily on the presence of food to retard emptying and 
provide sufficient liquid for effective buoyancy. 
1.11 Types of FDDS: 
4, 5, 26 
 
Based on mechanism of buoyancy, two distinctly different technologies have been utilized in 
the development of FDDS, which are effervescent system and non-effervescent system 
A. Effervescent system: 
Effervescent system include use of gas generating agents, carbonate(sodium bicarbonate) and 
other organic acids (citric acid and tartaric acid) to produce carbon dioxide(CO2) gas, thus 
INTRODUCTION 
 
Department of Pharmaceutics, Nandha College of Pharmacy, Erode Page 20 
 
reducing the density of the system and making it to float on the gastric fluid. The effervescent 
further classified into two types. 
(Ι)  Gas Generating Systems: 
1.   Intra Gastric Single Layer Floating Tablet 
      These are formulated by the CO2 generating agents and the drug within matrix tablet. These 
have a bulk density lower than gastric fluids and therefore remain floating in the stomach 
unflattering the gastric emptying rate for a prolonged period. The drug is slowly released at a 
desired rate from the floating system and after the complete release the residual system is 
expelled from the stomach and this leads to increase in GRT and better control over 
fluctuations in plasma drug concentration. 
2.  Intra Gastric Bilayered Floating Tablets: 
       These are also compressed tablets and contain two layers for: 
        Immediate release layer and Sustained release layer 
                                                                                                                        
 
                           Fig. 5: Intra Gastric Bilayered Floating Tablets 
3.  Multiple Unit type floating pills  
These systems consist of sustained release pills as „seeds‟ surrounded by double layers. The 
inner layer consists of effervescent agents while the outer layer is of swellable membrane 
layer. When the system is immersed in dissolution medium at body temperature it sinks at 
once and then forms swallowing pills like balloon and float as the density decreases 
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                                    Fig. 6: A multiple-unit oral floating dosage system                                               
ΙΙ. Volatile liquid/ vacuum containing systems: 
1. Intragastric Floating Gastroretentive Drug Delivery System: 
These systems can be made to float in the stomach because of floatation chamber, which may 
be a vacuum or filled with air or a harmless gas, while drug reservoir is encapsulated inside a 
microporous compartment 
 
 
 
 
 
 
                        Intragastric  
 
   Fig. 7: floating drug delivery device 
 
2. Inflatable Gastroretentive Delivery System: 
In these systems an inflatable chamber is incorporated, which contains liquid that gasifies at 
body temperature to cause the chamber to inflate in the stomach. These systems are 
fabricated by loading the inflatable chamber with a drug reservoir, impregnated polymeric 
matrix, and then encapsulated in a gelatin capsule. After oral administration of the capsule 
dissolve to release the drug reservoir together with the inflatable chamber. The inflatable 
chamber automatically inflates and retains the drug reservoir compartment in floating 
position. The drug continuously released from the reservoir into the gastric fluid. 
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 Fig. 8: Gastro-inflatable drug delivery 
3.  Intragastric Osmotically Controlled Drug Delivery System: 
It is comprised of an osmotic pressure controlled drug delivery device and an inflatable 
floating support in a biodegradable capsule. In the stomach, capsule quickly disintegrates to 
release the intragastric osmotically controlled drug delivery device. The inflatable support 
inside forms a deformable hollow polymeric bag that contains a liquid that gasifies at body 
temperature to inflate the bag. The osmotic pressure controlled drug delivery device consists 
of two components; drug reservoir compartment and an osmotically active compartment. The 
drug reservoir compartment is enclosed by a pressure responsive collapsible bag, which is 
Impermeable to vapour and liquid and has a drug delivery orifice. The osmotically active 
compartment contains an osmotically active salt and is enclosed within a semi permeable 
housing. In the stomach, the water in the GI fluid is continuously absorbed through the Semi 
permeable membrane into osmotically active salt. An osmotic pressure is thus created which 
acts on the collapsible bag and turns in forces the drug reservoir compartment reduce its 
volume and activate the drug reservoir compartment to reduce its volume and activate the 
drug release in Solution form through the delivery orifice 
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                     Fig. 9: Intragastric osmotic controlled drug delivery system                        
 
B. Non Effervescent Systems:
  
 The non effervescent FDDS is based on mechanism of swelling of polymer or bioadhesion to 
mucosal layer in GI tract. The most commonly used excipients in non-effervescent FDDS are 
gel forming or highly swellable cellulose type hydrocolloids, polysaccharides and matrix 
forming materials such as polycarbonates, polyacrylates, polymethaacrylates, polystyrenes 
etc .                                                   
                                         
                            Fig. 10: Principle of hydro dynamically balanced system      
                                          
The various types of systems are: 
 Single Layer Floating Tablets: 
They are formed by intimate mixing of drug with a gel forming hydrocolloid, which swells in 
contact with gastric fluid and maintain bulk density of less than unity. The air trapped by the 
swollen polymer confers buoyancy to these dosage forms. 
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 Alginate Beads:                                                                                                    
 Multi unit floating dosage forms were developed from freeze dried calcium alginate. 
Spherical beads of approximately 2.5mm diameter can be prepared by dropping sodium 
alginate into aqueous solution of calcium chloride, causing precipitation of calcium alginate 
leading to formation of porous system, which can maintain a floating force for over 12 hr. 
These floating beads gave a prolonged residence time of more than 5.5 hr. 
Hollow Microspheres: 
Multiple-unit hollow microspheres by emulsion solvent diffusion technique were prepared 
with drug and acrylic polymer. These were dissolved in an ethanol-dichloromethane 
mixture, and poured into an aqueous solution of PVA with stirring to form emulsion 
droplets. The rate of drug release in micro balloons was controlled by changing the polymer 
to drug ratio. Microballons were floatable in vitro for 12 hours when immersed in aqueous 
media. Radio graphical studies proved that microballons orally administered to humans were 
dispersed in the upper part of the stomach and retained there for 3 hours against peristaltic 
movement 
1.12 Advantages and Disadvantages of FDDS 
Advantages of FDDS: 
 Drugs that act locally in the stomach e.g. antacids, antibiotics for microbial based ulcer, 
etc. 
 Drugs that are absorbed primarily in the stomach e.g. Albuterol 
 Drugs those are poorly soluble in alkaline pH. 
 Drugs that have narrow absorption window for absorption of the drugs which are 
absorbed from the proximal part of the small intestine. E.g. riboflavin, Levodopa, PABA. 
Drugs that degrade in colon e.g. Captopril, Metoprolol 
Disadvantages of FDDS: 
 High variability in gastric emptying time due to variations in emptying process. 
 Drugs that cause irritation and leisions to gastric mucosa and unstable in gastric fluid 
cannot be formulated as FDDS 
 Drugs with unpredictable bioavailability, minimum effective concentration are achieved 
slowly. 
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1.13 INTRODUCTION TO HYPERTENSION 
8, 9
 
Hypertension is a chronic medical condition in which the blood pressure is elevated. 
It is also referred to as high blood pressure or shortened to HT, HTN or HPN. The word 
"hypertension", by itself, normally refers to systemic, arterial hypertension. 
Hypertension can be classified as either essential (primary) or secondary. Essential 
or primary hypertension means that no medical cause can be found to explain the raised 
blood pressure. It is common. About 90-95% of hypertension is essential 
hypertension. Secondary hypertension indicates that the high blood pressure is a result of 
(i.e., secondary to) another condition, such as kidney disease or tumours (adrenal 
adenoma or pheochromocytoma). 
Persistent hypertension is one of the risk factors for strokes, heart attacks, heart 
failure and arterial aneurysm, and is a leading cause of chronic renal failure. Even moderate 
elevation of arterial blood pressure leads to shortened life expectancy. At severely high 
pressures, defined as mean arterial pressures 50% or more above average, a person can expect 
to live no more than a few years unless appropriately treated  Beginning at a systolic pressure 
(which is peak pressure in the arteries, which occurs near the end of the cardiac cycle when 
the ventricles are contracting) of 115 mmHg and diastolic pressure (which is minimum 
pressure in the arteries, which occurs near the beginning of the cardiac cycle when the 
ventricles are filled with blood) of 75 mmHg (commonly written as 
115/75 mmHg), cardiovascular disease (CVD) risk doubles for each increment of 
20/10 mmHg.
 
1.14 Classification:
 
A recent classification recommends blood pressure criteria for defining normal blood 
pressure, prehypertension, hypertension (stages I and II), and isolated systolic hypertension, 
which is a common occurrence among the elderly. These readings are based on the average of 
seated blood pressure readings that were properly measured during 2 or more office visits. In 
individuals older than 50 years, hypertension is considered to be present when a person's 
blood pressure is consistently at least 140 mmHg systolic or 90 mmHg diastolic. Patients 
with blood pressures over 130/80 mmHg along with Type 1 or Type 2 diabetes or kidney 
disease require further treatment. 
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Table: 3 Classification of Hypertension 
Classification 
Systolic pressure Diastolic pressure 
mmHg kPa (kN/m
2
) mmHg kPa (kN/m
2
) 
Normal 90–119 12–15.9 60–79 8.0–10.5 
Prehypertension 120–139 16.0–18.5 80–89 10.7–11.9 
Stage 1 140–159 18.7–21.2 90–99 12.0–13.2 
Stage 2 ≥160 ≥21.3 ≥100 ≥13.3 
Isolated systolic 
hypertension 
≥140 ≥18.7 <90 <12.0 
Resistant hypertension is defined as the failure to reduce blood pressure to the 
appropriate level after taking a three-drug regimen (include thiazide diuretic). Guidelines for 
treating resistant hypertension have been published in the UK and US. 
Excessive elevation in blood pressure during exercise is called exercise hypertension. The 
upper normal systolic values during exercise reach levels between 200 and 230 mm 
Hg. Exercise hypertension may be regarded as a precursor to established hypertension at rest. 
1.15 Signs and Symptoms: 
Mild to moderate essential hypertension is usually asymptomatic. Accelerated 
hypertension is associate with headache; somnolence, visual disturbances, 
nausea and vomiting (hypertensive encephalopathy).Retinas are affected with narrowing of 
arterial diameter to less than 50% of venous diameter,copper or silver wire 
appearance, exudates, hemorrhages, or papilledema. Some signs and symptoms are especially 
important in infants and neonates such as failure to thrive, seizure, irritability or lethargy, 
and respiratory distress. While in children hypertension may cause headache, fatigue, blurred 
vision, epistaxis, and bell palsy. 
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Some signs and symptoms are especially important in suggesting a secondary medical 
cause of chronic hypertension, such as centripetal obesity, "buffalo hump," and/or wide 
purple abdominal striae and maybe a recent onset of diabetes suggest glucocorticoid 
excess either due to Cushing's syndrome or other cause.  Hypertension due to other secondary 
endocrine diseases such as hyperthyroidism, hypothyroidism, or growth hormone 
excess show symptoms specific to these disease such as in hyperthyrodism there may 
be weight loss, tremor, tachycardia or atrial arrhythmia, palmar erythema and sweating. Signs 
and symptoms associated with growth hormone excess such as coarsening off 
acialfeatures, prognathism, macroglossia,      , hyperpigmentation, and hyperhidrosis may 
occur in these patients. Other endocrine causes such as hyper aldosteronism may cause less 
specific symptoms such as  numbness, polyuria, polydipsia, hypernatraemia and metabolic 
alkalosis. A systolic bruit heard over the abdomen or in the flanks suggests renal artery 
stenosis. Also radio femoral delay or diminished pulses in lower versus upper extremities 
suggests  coarctation of the aorta. 
 Hypertension in patients with pheochromocytomas is usually sustained but may be 
episodic. The typical attack lasts from minutes to hours and is associated with 
headache, anxiety, palpitation, profuse perspiration, pallor, tremor, and nausea and vomiting. 
Blood pressure is markedly elevated, and angina or acute pulmonary edema may occur. 
In primary aldosteronism, patients may have muscular weakness, polyuria, and nocturia due 
to hypokalemia. Chronic hypertension often leads to left ventricular hypertrophy, which can 
present with exertional and paroxysmal nocturnal dyspnea. Cerebral involvement 
causes stroke due to thrombosis or hemorrhage from microaneurysms of small 
penetrating intracranial arteries. Hypertensive encephalopathy is probably caused by 
acute capillary congestion and exudation with cerebral edema, which is reversible. 
Signs and symptoms associated with pre-eclampsia and eclampsia can be  
proteinuria, edema, and hallmark of  eclampsia which is convulsions, other cerebral signs 
may precede the convulsion such as nausea, vomiting, headaches, and blindness. 
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2. REVIEW OF LITERATURE 
 
Josephine LJ, et al.
10
, The purpose of the research work was to prepare and evaluate 
the floating microspheres of stavudine as a model drug for prolongation of gastric retention 
time for oral delivery. Stavudine is a synthetic analog of reverse transcriptase inhibitor with 
short half-life (0.8 to 1.5hr). The floating microspheres of Stavudine were prepared by 
emulsion solvent diffusion method using Eudragit RS 100 as a rate controlling polymer. The 
floating microspheres were evaluated for micromeritic properties, particle size, % yield, in 
vitro buoyancy, incorporation efficiency and drug release. The size or average diameter of 
prepared microspheres were recognized and characterized by scanning electron microscopic 
methods. The prepared microspheres were found to be spherical and free flowing and remain 
buoyant for more than 12 hrs. The drug-loaded microspheres (A1) showed encapsulation 
efficiencies up to 88% and also showed good micromeritic properties for their suitability as 
oral dosage forms. The microspheres having lower densities exhibited good buoyancy effect 
and hence, these could be retained in the gastric environment for more than12 h. Thus, the 
present formulations would be capable of reducing the frequency of administration and the 
dose-dependent side effects associated with the repeated administration of conventional 
stavudine tablets. 
Prasanth KR, et al.
 11
, Present investigation describes preparation of microspheres by 
solvent evaporation and W/O emulsion solvent evaporation methods followed by in vitro 
characterization of microspheres to evaluate the effect of method of preparation on physical 
properties and drug release profile of microspheres. The microspheres were found to be 
discrete, spherical with free flowing properties. The morphology (Scanning Electron 
Microscopy), particle size distribution, entrapment efficiency and their release profiles were 
investigated. The yield was found to be maximum in case of solvent evaporation method. The 
mean geometric particle size of microspheres prepared by solvent evaporation method was 
found in the ranges of 40-50 μm and the microspheres prepared by W/O emulsion solvent 
evaporation method was found in a ranges of 126-150 μm, respectively. The microspheres 
formulation prepared by solvent evaporation method has shown greater encapsulation 
efficiency than W/O emulsion solvent evaporation method. The drug carrier interactions were 
investigated in solid state by Fourier Transform Infrared (FT-IR) spectroscopy study._ In 
vitro drug release rate for microspheres was found to be sustained over 8 hours. Hence, it can 
be concluded that the formulation prepared by solvent evaporation method, has potential to 
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deliver Losartan potassium in a controlled manner in a regular fashion over extended period 
of time in comparison to all other formulations and can be adopted for a successful oral 
delivery of Losartan potassium for safe management of hypertension._ All data are verified 
as statistically significant by using one way ANOVA at 5 % level of significance (p < 0.05). 
Sabyasachi M, et al.
 12
, in this study, fluconazole‐loaded ethyl cellulose microspheres 
were prepared by alginate facilitated water‐in‐oil‐in‐water (w/o/w) multiple emulsion solvent 
evaporation technique and the effect of micro‐environmental pH on the properties of 
microspheres was investigated. The inclusion of aqueous alginate solution of pH 6 into 
internal aqueous phase of the multiple emulsion led to higher drug entrapment efficiency 
(72.79%) of the microspheres than those prepared with solutions of either pH 4 or 8. The 
mean diameter of microspheres ranged from 291 to 331μm and appeared spherical under 
scanning electron microscope at all pH conditions. Carr’s index provided an indication of 
free‐flowing nature of all the microspheres. The drug release rate in either pH 1.2 HCl 
solution or pH 7.4 phosphate buffer saline (PBS) solution varied depending upon the 
micro‐environmental pH. The release profiles of microspheres having internal pH 4 always 
ran higher followed by pH 8 and pH 6 in either dissolution fluids. Irrespective of 
micro‐environmental pH, the drug release in pH 1.2 HCl solutions was slower than in pH 7.4 
phosphate buffer saline (PBS) solution, when compared up to 2 h. The drug release 
mechanism was unaffected by the micro‐environmental pH of the microspheres and was 
found to be controlled by Fickian diffusion. Thus, the change of pH of inner aqueous alginate 
phase could be beneficial for the entrapment of slightly water soluble drugs like fluconazole 
into ethyl cellulose microspheres. 
Durga J, et al.
 13
, The objective of this investigation is to develop a multi-unit gastro 
retentive sustained release dosage form of a water soluble drug, Ranitidine hydrochloride, 
from a completely aqueous environment avoiding the use of any organic solvent, which could 
cure peptic ulcer more efficiently by releasing the drug especially in stomach and also for a 
prolonged duration of time. A new emulsion gelation technique was used to prepare emulsion 
gel beads using sodium alginate as the polymer. The gel beads containing oil was prepared by 
gently mixing or homogenizing oil and water phase containing sodium alginate which was 
then extruded in to calcium chloride solution. The effects of factors like concentration of oil, 
curing time, drug: polymer ratio, alginate: pectin ratio and curing agent on drug entrapment 
efficiency, floating lag time, morphology and drug release were studied. Minimizing the 
curing time of beads leaded to enhanced drug entrapment efficiency. The use of sodium 
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alginate and combinations of sodium alginate and pectin were used to study the effect on the 
sustaining property of the formed beads. It was found that sodium alginate was not sufficient 
to sustain the drug release at gastric pH. Instead of it, appropriate combination of alginate and 
pectin could provide the sustain release of drug. The results show that these beads can entrap 
even a water soluble drug as Ranitidine hydrochloride in sufficient amount and also can 
successfully deliver the drug in stomach for a prolong duration of time without using any 
organic solvent and any time consuming step in the preparation. 
Najmuddin M, et al.
 14
, Floating drug delivery system is one of the novel drug 
delivery system. Floating drug delivery system have a bulk density less than gastric fluids 
and so remain buoyant in the stomach without affecting gastric emptying rate for a prolonged 
period of time. Ketoprofen is nonsteroidal anti-inflammatory drug with short elimination 
half-life. Floating microspheres of ketoprofen were prepared by solvent evaporation method 
using HPMC and two different grades of ethyl cellulose as polymer. The floating 
microsphere was evaluated such as micromeritic properties, particle size, percentage yield, in 
vitro buoyancy, incorporation efficiency, drug polymer compatibility (IR study), scanning 
electron microscopy and drug release of microsphere. Results show that as the concentration 
of polymer increases it affects the particle size, percentage yield, in vitro buoyancy and drug 
release of microsphere. The micromeritic properties were found to be good and scanning 
electron microscopy confirmed their hollow structure with smooth surface. Formulation F5 
prepared with HPMC 5 cps and ethyl cellulose 7‐10 cps which exhibited excellent 
micromeritic properties, percentage yield, in vitro buoyancy, incorporation efficiency and 
percentage drug release 98.88% for a period of 12 hrs. Results of our present study suggest 
that floating microsphere of ketoprofen can be successfully designed to develop sustained 
drug delivery which can reduce dosing frequency. 
Harshad P, et al.
 15
, Mucoadhesion is topic of current interest in the design of drug 
delivery system. Mucoadhesive microsphere exhibit a prolonged residence time at the site of 
application and facilitates an intimate contact with the underlying absorption surface and thus 
contributes to improved or better therapeutic performance of drug. Mucoadhesive drug 
delivery systems promises several advantages that arise from localization at a given target 
site, prolonged residence time at the site of drug absorption and an intensified contact with 
the mucosa increasing the drug concentration gradient. Hence, uptake and consequently 
bioavailability of the drug is increased and frequency of dosing reduced with the result that 
patient compliance is improved. In recent years such Mucoadhesive microspheres have been 
developed for oral, buccal, nasal, ocular, rectal and vaginal for either systemic or local 
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effects. The principles underlying the development of Mucoadhesive microsphere and 
research work carried out on these systems are reviewed here. 
Magharla D, et al.
 16
, to prepare and evaluate poly (ε-caprolactone) microspheres 
loaded with etoposide, a potent anti-cancer drug by solvent evaporation technique. Methods: 
The advent of biodegradable, polymeric drug delivery systems could be exploited 
successfully for maximizing the therapeutic efficacy of commonly used drugs. Etoposide was 
reported to be more effective when given over an extended period of time; hence poly (ε-
caprolactone) microspheres of etoposide were fabricated by oil in water solvent evaporation 
technique by varying the polymer concentration and the amount of PVA in external aqueous 
phase. The prepared microspheres were characterized for entrapment efficiency, drug 
loading, in vitro release studies and subjected to particle size analysis, scanning electron 
microscopy; differential scanning calorimetry, Fourier transform infrared spectroscopy.  
.  Pare A, et al.
 17
, Amlodipine besylate effervescent floating tablets were developed in 
ten different formulations (F1 to F10) by employing different grades of polymers and 
effervescent agents such as sodium bicarbonate and citric acid. The formulations were 
evaluated for various physical parameters, buoyancy studies, dissolution parameters and drug 
released mechanisms. F10 formulation showed maximum floating time of 24 hours and gave 
slow and maximum drug release of Amlodipine besylate spread over 24 hours and whereas 
Amlodipine besylate released from marketed tablet was rapid and maximum within 12 hours. 
Kotwal A, et al.
 18
, intragastric buoyant tablets, i.e., gastro retentive drug delivery 
systems of Amoxicillin trihydrate were prepared with the objective to obtain site-specific 
drug delivery for the stomach and to extend its duration of action. The sustained release of 
amoxicillin is desired because of its short biological half-life. Particularly to treat 
Helicobacter pylori infections, the sustained release is desired to be confined to the stomach. 
The intragastric buoyant tablets of amoxicillin will provide site-specific drug delivery and 
thereby extend its duration of action. The dosage form was designed by using HPMC K15M 
and HPMC K100 polymers as gelling agents, sodium bicarbonate as gas-generating agent and 
other excipients. Initially granules were prepared by wet granulation technique and 
compressed into tablets. The pharmaceutical properties of formulations, their buoyancy lag 
time and total floatation time and in vitro drug release were evaluated. It is found that the 
hardness of the tablet will affect the buoyancy characteristics of the dosage form. The in vitro 
release studies indicated that the floating dosage forms containing higher concentration of 
HPMC K100 showed slower release. The % drug release profile was in the order of F6 > F5 
> F4 > F3 > F2 > F1. The in vitro release data was treated with mathematical equations, and 
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it was concluded that Amoxicillin released from the tablet followed Peppas model with non-
Fickian diffusion. Hence gastro retentive drug delivery system of Amoxycillin trihydrate is a 
promising approach as it can lead to decrease in the frequency of administration and 
ultimately lead to better patient compliance. 
Sameer S, et al.
 19
, the present study was undertaken to prolong the release of orally 
administer. Captopril’s in the floating tablets by using different grade of hydroxyl propyl 
methyl cellulose. Formulations were optimized using different viscosity grades of 
hydroxypropylmethylecellulose. Lactose and citric acid were used in different concentration 
as a channeling and chelating agent to obtain best optimized formulation and designed to 
prolong the gastric residence time (GRT). Formulations were evaluated by floating lag time 
and in vitro drug release method. Results revealed that the effect of channeling and chelating 
agent at different concentration had significant effect on the release of the drug   from 
Hydrophilic matrix tablet. Three different viscosity grades of hydroxylpropylrmethyle 
cellulose namely K100M, K 15M and K 4M were used as a floating polymer or intention of 
polymer. It was observed that different viscosities not only influence the drug release from 
hydrophilic matrix but they also affect the floating properties of tablets. Dissolution profiles 
were subjected for various kinetic treatments to analyze the release pattern of the drug and we 
found that drug release by diffusion mechanism and followed square root kinetics or 
Higuchi’s kinetics. The in vitro release profiles of drug from all the plots shows high linearity 
(r2= 0.9813 to 0.9954). Optimized formulations were again subjected for thickness, friability, 
hardness, uniformity of content, uniformity of weight, in vitro dissolution. Floating lag time, 
floating time and stability studies. Results revealed that the floating formulation of the 
Captopril is the best formulation to obtain better therapeutic effect and 
hydroxypropylrmethylecellulose at a concentration of 35% up to some extent it increases the 
Bioavailability of the drug to retain the dosage form on the desired site for effective period of 
the time. 
Upendarrao G, et al.
 20
, the present investigation concerns the development of Hydro 
dynamically balanced tablets of Ciprofloxacin Hydrochloride, are designed to prolong the 
gastric residence time after oral administration and thereby increasing drug bioavailability. 
Floating tablets of Ciprofloxacin Hcl were prepared by direct compression using HPMC 
K4M and HPMC K15M as polymers along with Sodium bicarbonate as gas generating agent. 
The tablets were evaluated for in-vitro buoyancy, dissolution studies and physical 
characteristic viz. Density, Hardness, Friability, Thickness and Weight variation. Further, 
tablets were evaluated for in-vitro release characteristic for 12 hrs. It is found that the 
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hardness of the tablets affects the Buoyancy characteristic of the dosage form. All 
formulations possessed good floating properties with total floating time more than 12 hrs. 
The in-vitro release studies indicated that the floating tablets of Ciprofloxacin Hcl containing 
200mg HPMC K15M (F4) showed sustained release when compared with the marketed 
product and provides a better option for controlled release action and improved 
bioavailability. 
Ajay B, et al.
 21
, Ciprofloxacin HCl belong to the fluoroquinoline derivatives which is 
widely used in the long term therapy for treatment of a wide range of infections including 
anthrax, biliary tract infection, bone and joint infection, gastrointestinal including traveler’s 
diarrhoea and Campylobacter enteritis, Shiegella, meningococcal meningitis prophylaxis, 
surgical infection prophylaxis, tuberculosis, leprosy and topically in the treatment of eye 
infections. Hence there is a potential need for floating tablet as sustained release dosage form 
for this drug. HPMC and carbomer are the polymers, used as suspending agent, viscosity 
increasing agent and tablet binder coating agents. In the present study, it was aimed to 
formulate floating tablet of ciprofloxacin HCl with HPMC and carbomer in different 
proportion (4%, 8% and 12%) by direct compression techniques using polymers lactose, 
Magnesium Streate, talc with sodium bicarbonate. All the prepared formulation were found to 
complies with the official tests like precompression parameter like angle of repose and post 
compression parameters like Shape, tablet dimensions, hardness, friability test, weight 
variation test, floating test, content uniformity and in-vitro dissolution study. In-vitro release 
studies were carried out using USP XXII dissolution test apparatus. The mean percentage of 
ciprofloxacin released at various time intervals was calculated and plotted against time. The 
mechanism of drug release with all the formulations was dominantly diffusion and followed 
zero order kinetics. It was observed that the integrity of the drug is not affected by 
formulation procedure. The results revealed the drug polymer ratio showed greater drug 
release than other formulations. 
Subhash PCB, et al.
 22
, the aim of the present work was to prepare floating tablets of 
diltiazem HCl using xanthan gum as carrier. Diltiazem HCl is a calcium channel blocker used 
in treatment of several diseases of the cardiovascular system, especially angina and 
hypertension. It has elimination half-life of about 3.5 hrs. The formulations were prepared by 
varying the concentrations of xanthan gum and sodium bicarbonate. The tablets were 
prepared by direct compression technique using PVP K-30 as a binder and sodium 
bicarbonate for development of CO2. The prepared floating tablets were evaluated for tablet 
properties such as hardness, thickness, friability, weight variation, floating property, 
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compatibility using DSC and FTIR. In vitro dissolution was carried out for 12 hrs in 0.1N 
H
prepared formulations had desired floating lag time and constantly floated on dissolution 
medium by maintaining the matrix integrity. The drug release from prepared tablets was 
found to vary with varying concentration of the polymer, xanthan gum. From the study it was 
concluded that floating drug delivery system can be prepared by using xanthan gum as a 
carrier. 
Shishu et al.
 23
, 5-Fluorouracil (5-FU) has been the most widely used drug for the 
chemotherapy of gastro intestinal cancer for many decades.The present investigation 
concerns the development and evaluation of single unit fl oating tablets of 5-FU which, after 
oral administration, are designed to prolong the gastric residence time, increase drug 
bioavailability and target the stomach cancer. Methods: A fl oating drug delivery system 
(FDDS) was developed using gas-forming agents, like sodium bicarbonate, citric acid and 
hydrocolloids, like hydroxypropyl methylcellulose (HPMC) and Carbopol 934P. The 
prepared tablets were evaluated in terms of their physical characteristics, in vitro release, 
buoyancy, buoyancy lag-time and swelling index. The formulations were optimized for the 
type of fi ller, like lactose, microcrystalline cellulose (MCC) and dicalcium phosphate (DCP) 
as well; different viscosity grades of HPMC and concentrations. 
Sreekanth S, et al.
 24
, the main aim of the study was to design and evaluate nifedipine 
floating matrix tablets.Hydroxy prophyl methyl cellulose (HPMC K100M) was used as a 
polymer. About 15-35 % of HPMC can be used as a polymer in the extended release 
formulations. So, here the polymer was used in the range of 16-36 %. Sodium bicarbonate 
(40%) is used as a gas generating agent. It can be used in the range of 25-50 %. The granules 
are prepared by wet granulation method. The prepared granules were evaluated for the bulk 
density, tapped density, bulkiness, angle of repose, compressibility index and hausner ratio. 
The values indicate good flow property. The compressed tablets were evaluated for hardness, 
uniformity of weight, friability, drug content, buoyancy lag time and duration of buoyancy. 
All the readings are within the prescribed limits. There was no interaction between the drug, 
polymer and excipients it was found out by IR studies. The in vitro release data were fitted to 
different order of reactions such as zero order, first order, higuchis reaction, Hixson crowell 
reaction and korsmeyer peppas reaction. The drug release follows Korsmeyers – Peppas 
reaction. The mechanism of drug release is by non-fickian motion. The in vitro drug release 
data indicate that the release of the drug depends upon the proportion of polymer present in 
the formulation. As the polymer ratio increases the release rate of the drug is prolonged. 
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Vaishali S, et al.
 25
, Success of oral drug delivery system depends on its degree of 
absorption through GIT. Thus, the idea of enhancing drug absorption in the GIT pioneered 
the idea of development of Gastroretentive drug delivery system. To design and evaluate the 
performance of GRDDS, it is important to understand the relevant anatomy and physiology 
of the GI tract. To achieve gastric retention, the dosage form should satisfy certain 
requirements; primarily, the dosage form must be able to withstand the forceful peristaltic 
waves in the stomach and the constant contractions, grinding and churning. To function as a 
gastric retention device, it must resist premature gastric emptying. Once the purpose has been 
served, the device should be removed from the stomach with ease. Floating DDS or 
hydrodynamically balanced systems (HBS) have a bulk density lower than the gastric fluids 
(<~1.004 g/cm³), and thus remain buoyant in the stomach without affecting the gastric 
emptying rate for a prolonged period of time. Using FDDS one can easily increase the 
absorption of gastric secretion-labile drug 
Praveen N, et al.
 26
, Drugs with narrow absorption window in the gastrointestinal 
tract have poor absorption. Therefore, gastroretentive drug delivery systems (GRDDS) have 
been developed, which prolong the gastric emptying time. Several techniques such as floating 
drug delivery system, low density systems, raft systems, mucoadhesive systems, high density 
systems, superporous hydrogels and magnetic systems, have been employed. Floating drug 
delivery systems have a bulk density less than gastric fluids and so, remain buoyant in the 
stomach for a prolonged period of time, releasing the drug slowly at the desired rate from the 
system. Dosage forms available as gastric floating systems include tablets, capsules, granules 
and microspheres. This review on GRDDS attempts to compile the available information 
with all the possible mechanisms used to achieve gastric reventions. 
Ferdous K, et al.
 27
, This investigation describes the preparation and in vitro 
evaluation of gastroretentive floating tablet of theophylline. Two hydrophilic cellulose 
derivatives, Methocel K100M and Methocel K15MCR were evaluated for their gel forming 
and release controlling properties. Sodium bicarbonate and citric acid were incorporated as 
gas generating agents. The effects of soluble components (sodium bicarbonate and citric 
acid), gel forming agents and amount variation of theophylline on drug release profile and 
floating properties were investigated. Tablets were prepared by direct compression technique. 
Formulations were evaluated for in vitro buoyancy and drug release study was evaluated for 
eight hours using USP XXII paddle-type dissolution apparatus using 0.1N HCl as dissolution 
medium. The release mechanisms were explored and explained with zero order, first order, 
Higuchi and Korsmeyer equations. The release rate, extent and mechanisms were found to be 
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governed by polymer and floating agent content. The content of active ingredient was also a 
vital factor in controlling drug release pattern. It was found that polymer content and amount 
of floating agent significantly affected the mean dissolution time, percentage drug release 
after 8 hours, release rate constant and diffusion exponent. 
Anil G, et al.
 28
, the present study was undertaken with an aim to formulation 
development and evaluation of gastroretentive floating tablets of venlafaxine hydrochloride, 
which releases the drug in a sustained manner over a period of 12 hours. Three different 
viscosity grades of Hydroxypropyl methylcellulose (HPMC) namely K4M, K15M, and 
K100M were used for the preparation of tablets. The tablets were prepared by direct 
compression and evaluated for tablet thickness, weight variation, tablet hardness, friability, in 
vitro buoyancy test, in vitro drug release and Fourier transform infrared (FT-IR) 
spectroscopy. Formulation F3 can be considered as an ideal or optimized formulation for 
gastroretentive floating tablet of venlafaxine HCl. The optimized formulation showed 
sufficiently sustained drug release and remained buoyant on the surface of the medium for 
more than 12 hours. As the concentration of HPMC increases in the formulation the drug 
release rate was found to be decreased. It can be concluded that floating drug delivery system 
of venlafaxine HCl can be successfully formulated as an approach to increase gastric 
residence time and thereby improving its bioavailability. 
Vishnu MP et al.
 29
, Verapamil hydrochloride using different hydrocolloid polymers 
including Carbopol (CP 934P; CP 940P), Hydroxypropylmethylcellulose (HPMC K4M; 
HPMC K15 M; HPMC E15) and Xanthan gum was done by the direct compression 
technology. The tablets were evaluated for the physicochemical parameters such as weight 
variation, thickness, friability, hardness, drug content, in vitro buoyancy studies, swelling 
index study, in vitro dissolution studies. The prepared tablets exhibited satisfactory Physico-
chemical characteristics. Tablet bouncy was achieved by adding an effervescent mixture of 
sodium bicarbonate and anhydrous citric acid. The in vitro dissolution studies were carried 
out in a USP XXII apparatus 2 in 0.1N HCl. All the gastro retentive tablets showed good in-
vitro buoyancy. The tablet swelled radially and axially during in-vitro buoyancy studies. The 
selected tablets (F6) containing Xanthan gum released approximately 97.89% drug in 24 h in 
vitro dissolution study, while the buoyancy lag time was 24.6 ± 3.2 second and the tablet 
remained buoyant for > 24 h. Zero order and non-Fickian release transport was confirmed as 
the drug release mechanism for the selected tablets (F6). Tablets (F6) showed no significant 
change in physical appearance, drug content, total buoyancy time or in vitro dissolution study 
after storage at 45 °C/75% RH for three months. 
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3. DRUG PROFILE30 
Name: Felodipine 
Description: 
 Felodipine is a long-acting 1,4-dihydropyridine calcium channel blocker (CCB)b. It acts 
primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels 
in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, 
Felodipine prevents calcium-dependent myocyte contraction and vasoconstriction. Felodipine is 
the most potent CCB in use and is unique in that it exhibits fluorescent activity. In addition to 
binding to L-type calcium channels, Felodipine binds to a number of calcium-binding proteins, 
exhibits competitive antagonism of the mineralcorticoid receptor, inhibits the activity of 
calmodulin-dependent cyclic nucleotide phosphodiesterase, and blocks calcium influx through 
voltage-gated T-type calcium channels. Felodipine is used to treat mild to moderate essential 
hyperten. 
Structure: 
 
 
Fig. 11: Structure of felodipine 
IUPAC name: 3-ethyl 5-methyl 4-(2, 3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-
dicarboxylate 
Molecular formula: C18H19Cl2NO4
 
Molecular weight: 384.259 g/mol. 
Half-life: 2 hrs- 4.8 hrs 
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Mechanism of action:  
Felodipine decreases arterial smooth muscle contractility and subsequent vasoconstriction 
by inhibiting the influx of calcium ions through voltage-gated L-type calcium channels. It 
reversibly competes against nitrendipine and other DHP CCBs for DHP binding sites in vascular 
smooth muscle and cultured rabbit atrial cells. Calcium ions entering the cell through these 
channels bind to calmodulin. Calcium-bound calmodulin then binds to and activates myosin light 
chain kinase (MLCK). Activated MLCK catalyzes the phosphorylation of the regulatory light 
chain subunit of myosin, a key step in muscle contraction. Signal amplification is achieved by 
calcium-induced calcium release from the sarcoplasmic reticulum through ryanodine receptors. 
Inhibition of the initial influx of calcium decreases the contractile activity of arterial smooth 
muscle cells and results in vasodilation. The vasodilatory effects of Felodipine result in an 
overall decrease in blood pressure. Felodipine may be used to treat mild to moderate essential 
hypertension. 
Protein binding: 99%, primarily to the albumin fraction. 
Metabolism: Hepatic metabolism primarily undergoes via cytochrome P450 3A4. Six 
metabolites with no appreciable vasodilatory effects have been identified. 
Route of administration: oral 
Dose: 200 mg per/day. 
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4. POLYMERS PROFILE31 
4.1 SODIUM ALGINATE 
Nonproprietary Name: 
BP: Sodium Alginate 
PhEur: Sodium Alginate 
USP-NF: Sodium Alginate 
Synonyms: algin, alginic acid, sodium salt, sodium polymannuronate 
Chemical Name: Sodium alginate 
Empirical Formula:  
Sodium alginate consists chiefly of the sodium salt of alginic acid, which is a mixture of 
polyuronic acids composed of residues of D-mannuronic acid and L-guluronic 
Structure: 
   
Fig. 12: Structure of Sodium alginate 
Molecular formula: （C6H7O6Na) 
Description:  
 White or light yellow, vagiform powder, odorless, tasteless, dissolve in water, 
insoluble in ethanol and ether. 
Method of Manufacture: 
  Alginic acid is extracted from brown seaweed and is neutralized with sodium 
bicarbonate to form sodium alginate. 
Acidity/alkalinity:   pH _7.2 for a 1% w/v aqueous solution. 
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Functional Category: 
Stabilizing agent, suspending agent, tablet and capsule disintegrant, tablet binder, 
viscosity increasing agent. 
Applications in Pharmaceutical Formulation or Technology: 
Sodium alginate is used in a variety of oral and topical pharmaceutical formulations. 
In tablet formulations, sodium alginate may be used as both a binder and disintegrant; it has 
been used as a diluent in capsule formulations. Sodium alginate has also been used in the 
preparation of sustained-release oral formulations since it can delay the dissolution of a drug 
from tablets, capsules, and aqueous suspensions.  
 Description: 
Sodium alginate occurs as an odorless and tasteless, white to pale yellowish-brown 
colored powder. 
 Solubility: 
 Practically insoluble in ethanol (95%), ether, chloroform, and ethanol/water mixtures 
in which the ethanol content is greater than 30%. Slowly soluble in water, forming a viscous 
colloidal solution. 
 Viscosity (dynamic):  
Various grades of sodium alginate are commercially available that yield aqueous 
solutions of varying viscosity. Typically, a 1% w/v aqueous solution, at 20
0
C, will have a 
viscosity of 20–400 mPa s (20–400 cP).  
 Stability and Storage Conditions: 
Sodium alginate is a hygroscopic material, although it is stable if stored at low 
relative humidity and a cool temperature.  
Incompatibilities: 
Sodium alginate is incompatible with acridine derivatives, crystal violet, phenyl 
mercuric acetate and nitrate, calcium salts, heavy metals, and ethanol in concentrations 
greater than 5%.  
Method of Manufacture: 
Alginic acid is extracted from brown seaweed and is neutralized with sodium 
bicarbonate to form sodium alginate. 
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Safety: 
It is generally regarded as a nontoxic and nonirritant material, although excessive oral 
consumption may be harmful.  
Applications: 
 Sodium alginate is used in a variety of oral and topical pharmaceutical formulations. 
 In tablet formulations, sodium alginate may be used as both a binder and disintegrates 
 It  has been used as a diluent in capsule formulations  
 Sodium alginate has also been used in the preparation of sustained release oral 
formulations since it can delay the dissolution of a drug from tablets, (5–7) 
capsules,(8) and aqueous suspensions. 
 In topical formulations, sodium alginate is widely used as a thickening and 
suspending agent in a variety of pastes, creams, and gels, and as a stabilizing agent for 
oil-in-water emulsions. 
 Sodium alginate has been used for the aqueous microencapsulation of drugs, in 
contrast with the more conventional microencapsulation techniques which use 
organic-solvent systems.   
 It has also been used in the formation of nanoparticles. 
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4.2 HYDROXY PROPYL METHYLCELLULOSE 
 
1. Nonproprietary Name: 
BP: Hypromellose,USP: Hypromellose 
2.  Synonyms: 
Hydroxypropyl methylcellulose, HPMC, hypromellosum, Methocel, methylcellulose 
propylene glycol ether, methyl hydroxypropylcellulose, Metolose, MHPC.  
3. Chemical Name:  Cellulose hydroxypropyl methyl ether 
4. Empirical Formula and Molecular Weight: 
The PhEur 6.3 describes hypromellose as a partlyO-methylated and O-(2-
hydroxypropylated) cellulose.  Molecular weight is approximately 10 000–1 500 000. 
5. Structural Formula:             
 
Fig. 13: Structure of HPMC 
Where R is H, CH3, or CH3CH(OH)CH2 
6. Applications in Pharmaceutical Formulation or Technology: 
Hypromellose is widely used in oral, ophthalmic, nasal, and topical pharmaceutical 
formulations. In oral products, hypromellose is primarily used as a tablet binder, in film-
coating, and as a matrix for use in extended release tablet formulations. Concentrations 
between 2% and 5% w/w may be used as a binder in either wet- or dry-granulation processes. 
High-viscosity grades may be used to retard the release of drugs from a matrix at levels of 
10–80% w/w in tablets and capsules. Hypromellose is also used in liquid oral dosage forms 
as a suspending and/or thickening agent at concentrations ranging from 0.25–5.0%.  
7. Description: 
Hypromellose is an odorless and tasteless, white or creamy-white fibrous or granular 
powder. 
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8. Solubility: 
 Soluble in cold water, forming a viscous colloidal solution; practically insoluble in 
hot water, chloroform, ethanol (95%), and ether, but soluble in mixtures of ethanol and 
dichloromethane, mixtures of methanol and dichloromethane. 
9. Stability and Storage Conditions: 
Hypromellose powder should be stored in a well-closed container, in a cool, dry 
place. 
10. Safety: 
Hypromellose is generally regarded as a nontoxic and nonirritating material, although 
excessive oral consumption may have a laxative effect. 
 
4.3 PEG 4000 
PEG 4000 Is a Mixture of the poly condensation products of ethylene oxide and water 
obtained under controlled conditions. 
Molecular formula: HOCH2(CH2OCH2)nCH2OH. 
Description: 
A creamy white, wax like solid, powder (or) flakes, odour faint and characteristic. 
Functional use: It is used as a clarifying agent, Carrier. 
Solubility: Soluble in water. 
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5. AIM AND OBJECTIVE 
 
Floating drug delivery of particular interest for drugs that act locally in the stomach, 
and are primarily absorbed in the stomach, they are poorly soluble at an alkaline pH, and 
have a narrow window of absorption, and which are unstable in the intestinal or colonic 
environment. To provide good floating behavior in the stomach the density of the device 
should be less than that of the gastric contents. 
Drugs that have narrow absorption window in upper part of released GI tract i.e., 
stomach and small intestine, which is due to short transit time of dosage form formulation of 
this drug leave upper part of tract and reaches to non – absorbing distal regiment, resulting 
lesser bioavailability. Floating drug delivery systems prolong the drug release rate from 
formulation in the stomach and upper part of small intestine until all drugs are released for 
the desired period of time. 
The drug of choice felodipine is an effective anti-hypertensive drug. The main 
purpose of the present research was to develop a controlled drug delivery system of 
felodipine for pre-oral administration using biocompatible sodium alginate polymer in order 
to increase its biological half life and determine the influence of formulation and preparation 
variables on micro particles characteristics such as, drug incorporation and in-vitro drug 
release.  
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6. PLAN OF WORK 
 
The present work carried out to prepare and evaluate the floating microsphere the 
following experimental protocol was therefore design to allow a systemic approach to study 
 Preformulation studies 
 FT-IR study 
 Preparation of standard curves 
 Formulation of floating microspheres 
 Evaluation tests 
 Tapped density 
 Angle of repose 
 Compressibility index 
 Drug entrapment 
 Particle size analysis 
 Percentage yield 
 Floating behavior of microspheres 
 Scanning electron microscopy 
 In vitro release study 
 Stability study 
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7. MATERIALS AND EQUIPMENT 
Table no.4: MATERIALS USED 
 
S. No Chemical Name Supplier 
1 Felodipine Micro labs, Pvt, Ltd Bengaluru 
2 PEG 4000 Lobachemi, Pvt Ltd.Mumbai 
3 Sodium alginate Lobachemi, Pvt Ltd.Mumbai 
4 HPMC K 100 Lobachemi, Pvt Ltd.Mumbai 
5 Ethonol          S.D fine chemicals Pvt Ltd, Mumbai 
6 Dichloro methane Merck Pvt Ltd, Mumbai 
7 Conc.HCL Nice chemicals, Pvt Ltd, Cochin 
8 Tween 80 S.D fine chemicals Pvt Ltd, Mumbai 
9 n-hexne Qualigens fine chemicals pvt ltd. India 
 
Table no. 5: EQUIPMENTS USED 
 
S. 
No 
Name of the Equipment Supplier 
1 Pippetes,Beakers Borosil 
2 Hot air oven Sunbimmanfacture Pvt. Ltd 
3 Uv-spectro photo meter Shimadzu 
4 Dissolution apparatus Electro lab 
5 Magnetic stirrer Sunsim, India 
6 PH meter  Elico 
7 Scanning eletron microscopy JEOL, JSM-670F,Japan 
8 sieve Jayanth scientific IND, Mumbai 
9 FT –IR apparatus Shimadzu 
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Preformulation studies 
8.1 FT-IR STUDIES
10
: 
The FT-IR analysis was done conducted for the analysis of drug polymer interaction 
andstability of the drug during microencapsulation process. The FT-IR spectrum of pure 
felodipine, sodium alginate, HPMC K 100, and PEG 4000.was studied. The physical 
mixtures of the floating microspheres formulation also were recorded.  
 
8.2 UV-Visible Spectroscopy: 
 Standard graph of Felodipine: 
The Stock solution of felodipine was prepared by accurately dissolving 100 mg in 100 
ml of acidic buffer of pH 1.2. From this 10ml was taken and diluted up to 100 ml with acidic 
buffer pH 1.2 to get 100 µg/ml solutions. From this 10µg/ml solution was prepared by diluting 
10ml to 100ml with acidic buffer pH 1.2. From this 2, 4, 6 & 8 to 10 ml with acidic buffer pH 
1.2.  
8.3 Preparation of Floating Microspheres: 
                                  Table no. 6: Formulation of floating microsphere 
Formulation Drug PEG 4000 
Sodium 
alginate 
HPMC K 100 
F1 100 mg 300 mg - - 
F2 100 mg 500 mg - - 
F3 100 mg - 300 mg - 
F4 100 mg - 500 mg - 
F5 100 mg - - 300 mg 
F6 100 mg - - 500 mg 
 
The formulation of the floating microsphere was performed by taking the drug and the 
polymer in the ratio of 1:3 and 1:5. The floating microspheres were prepared by solvent 
evaporation method 
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SOLVENT EVAPORATION METHOD: 
30 
The solvent evaporation method for felodipine microsphere was as follows: 
1 a) Preparation of sodium alginate solution, HPMC K100, PEG 400 the ratio of 1:3 
Weighed amount of sodium alginate was added into 100 ml of distilled water in 
250ml beaker. The remaining HPMC K100 and PEG 4000 also prepared individually. 
b)  Preparation of sodium alginate solution, HPMC K100, PEG 400 the ratio of 1:5 
Weighed amount of sodium alginate was added into 100 ml distilled water in 250 ml 
beaker. and similarly The remaining HPMC K100 and PEG 4000 were also prepared 
individually. 
2) Preparation of organic phase: 
0.5 ml ground nut oil was added into the 100 mg of felodipine in 100 ml beaker. 
3) Preparation of cacl2 solution: 
40 gms of cacl2 was added in 200 ml distilled water in 250 ml beaker. The sodium 
alginate, HPMC K100, PEG 4000, solutions were added into oily phase (organic phase) 
individually. So ultimately primary solutions were prepared. With the help of micro syringe 
above prepared primary emulsions were added in the 20% CaCl2 solution. Before the addition 
of  primary into 20% cacl2 which was kept initially on magnetic stirrer with a constant speed 
set at 200 rpm and at constant room temperature (37.5±1 ºcelcius), n-hexane was added to 
avoid the collapse of drops of primary emulsions during the addition in 20% CaCl2,because 
n-hexane play an important role in microsphere formation. 
 
8.4 Evaluation tests: 
The following parameters are determined for floating microspheres of felodipine. 
8.4.1. Tapped Density: 
32, 33
 
The floating microspheres were tapped gently as surface till the powder occupies 
maximum volume and noted the volume as tapped volume. The mechanical tapping of 
cylinder was carried out manually 500 times. The tapped density was calculated in g/cm
2
 by 
the following formula. 
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8.4.2. Angle of Repose:
 32, 33
 
The frictional forces in floating microspheres can be measured by the angle of repose 
θ. This is the maximum angle possible between the surface of a pile of microspheres and the 
horizontal plane. 
A funnel is fixed at a particular height ‘h’ on a burette stand. A white paper is placed bellow 
the funnel. The sample is passed slowly through the funnel until it forms a pile further 
addition of drug stopped as soon as the drug pile touches the tube of the funnel. Circle of the 
pile of drug is drawn without disturbing the pile of radius of the pile is noted. Angle of repose 
is calculated from the following formula:           Table no. 7:  
 
                                                             Tanθ=h/r 
Θ=angle of repose degrees,   h=height of pile, r=radius of the pile in cm 
 
8.4.3. Carr’s compressibility index: 32, 33 
The percentage compressibility index was calculated according to following formula. 
%compressibility index= [1-V/V0] x 100 
Where V and VO are the volume of the sample after and before the standard tapping respectively. 
Each determination was made in triplicate. 
8.4.4 Drug entrapment: 
34
 
The various formulations of the floating microspheres were subjected for drug 
content. 100mg of floating microspheres from all batches were accurately weighed. The 
microspheres were dissolved with 10ml ethanol in in 100ml volumetric flask and makeup the 
volume with 1.2 pH acidic buffer. The resulting solution is then filtered through whatmann 
S.N0 Angle of repose (θ) Carr’s index Type of flow 
1 <25 5-15 Excellent 
2 25-30 12-16 Good 
3 30-40 18-21 Passable 
4 - 23-35 Poor 
5 - 33-38 Very poor 
6 >40 >40 Extremely poor 
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filter paper no 44.after filtration, from the solution 10ml was taken out and diluted up to 
100ml with pH1.2 .again from the solution taken out and diluted up to 10ml with pH1.2 and 
the absorbance was measured at 362nm against pH1.2 as blank. The percentage drug 
entrapment was calculated as follows. 
 
8.4.5 Particle size analysis:
 32, 33
 
Particle size analysis plays an important role in determining the release characteristic 
and floating property. The size of floating microspheres were measured by using an optical 
microscope, and the mean practical size was calculated by measuring nearly 200 particles 
with the help of calculated ocular micrometer. 
  
8.4.6 Percentage yield:
 14
 
The prepared microspheres weighed from different formulations the measured weight 
was divided by the total amount of all non -volatile components which were used for the 
preparation of microspheres. 
 
8.4.7 Buoyancy percentage: 
30
 
100 mg of floating microspheres were placed in pH1.2 (900ml) containing 0.02% of 
tween80.the mixture was stirred with paddle at 100 rpm. The layer of buoyant microsphere 
was pippeted and separated by filtration at 1, 2,3, 4, 5,6,7,8,10, and 12.hrs the collected 
microspheres were dried in a desiccators over night. The percentage of microspheres was 
calculated by the following equation: 
 
.  
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8.4.8 Scanning electron microscopy: 
36
 
Dry microspheres were placed on an electron microscope brass stub encoated with 
gold in an ion sputter.Then picture of microsphere were taken by random scanning of stub. 
The SEM analysis of the microspheres was carried out by using JEOL, JSM-670F japan 
(Sastra University, tanjavur).the microspheres were viewed at an accelerating voltage of 3.0. 
 
8.4.9 In-vitro Drug release studies: 
35
 
The drug release rate from floating microspheres was carried out using the USP type –
II dissolution basket assembly. A weighed amount of floating microspheres equivalent to 100 
mg drug were discrete in 900 ml of pH1.2 maintained at 37±0.5 ºC and stirred at 100 rpm. 
1ml sample was withdrawn at predetermined intervals and filtered and equal volume of 
dissolution medium replaced in the vessel after each withdrawal to maintain sink condition. 
The collected samples were suitably diluted with pH 1.2 and analyzed spectrophtometrically 
at 362 nm to determine the concentration of drug present in the dissolution medium.  
 
8.4.10 Stability studies: 
22
 
The stability study was carried out for the all formulations by exposing it to different 
temperatures 5-8 ºC, 27 ºC and 40 ºc for 3 months. The samples were analyzed for drug 
content at the regular intervals. 
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9. RESULTS AND DISCUSSION 
 
9.1 FT-IR Studies: 
The drug and polymer interaction was studied by taking FT-IR .Infrared spectra of drug 
and polymers were carried out by using KBR pellet technique. The spectrum was observed for 
the drug and the polymers individually and when the drug mixed with the different polymers and 
the range of the mixture was compared with the drug to find whether there is any drug polymer 
interaction. 
 
 
 
 
 
S. No Type of 
bond 
Standard 
wave 
number 
Observed wave number 
Felodipine Felodipine 
+ Sod. 
Alginate 
Felodipine 
 + PEG4000 
Felodipine 
+HPMC 
1 N-H 3400 3370.72 3368.79 3371.68 3457.52 
2 C-X 
chloride 
785-540 729.12 729.12 731.05 728.15 
3 C =C 
aromatic 
1600 & 
1475 
1620.26 
1495.85 
1616.40 
1497.78 
1620.28 
1494.88 
1611.58 
1460.16 
4 C=O 1725-
1700 
1697.41 1706.09 1620.26 1708.99 
5 O-H 3500 3506.70 3629.19 3636.90 3457.52 
6 C-O 1300-
1000 
1307.78 1307.78 1308.75 1008.85 
7 C-H 
(stretch) 
3000-
2850 
2983.98 2901.04 2881.78 2990.76 
8 -CH3 
(Bend) 
1450& 
1375 
1436.05 
1381.08 
1430.26 
1364.68 
1472.70 
1350.22 
1460.16 
1371.43 
9 -CH2 
(Bend) 
1465 1495.85 1497.78 1472.70 1460.16 
10 Alkenes 
(stretch) 
3100-
3000 
3097.78 3093.92 3232.80 3071.74 
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Table no 8: Functional group Analysis of drug and Polymers 
 
 
Fig: 15 Spectra of Felodipine 
 
 
Fig: 16 Spectra of PEG 4000 
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Fig: 17 Spectra of sodium alginate 
 
 
Fig: 18 Spectra of HPMC 
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Fig: 19 Spectra of Felodipine with PEG4000 
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Fig: 20 Spectra of Felodipine with sodium alginate 
 
 
Fig: 21 Spectra of Felodipine with HPMC 
 
The results showed that there was no drug polymer interaction when IR spectra of pure 
drug felodipine in the presence of PEG 4000, sodium alginate and HPMC K 100, thus revealing 
compatibility of the selected drug in different polymers. 
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9.2 Standard Graph of Felodipine:  
Different concentrations of felodipine from 2 to 10µg/ml were prepared and the 
absorbance was taken at 362 nm against pH1.2 acidic buffer and graph was plotted between 
concentration and absorbance. 
Table no. 9: Spectrophotometric analysis of formulation 
 
 
 
 
 
 
 
 
 
Fig: 22 
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Time in hrs 
Standard curve of Felodipine 
S.No Concentration(µg/ml) Absorbance 
1. 0 0 
2. 2 0.205 
3. 4 0.422 
4. 6 0.580 
5. 8 0.842 
6. 10 0.934 
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9.3 Evaluation of microspheres: 
9.3.1 Tapped density: 
The tapped density was determined by tapping method the tapped density value of different microspheres 
range from 0.303 – 0.402 g/cc as shown in the table.  
Table 10 
Formulation Tapped density g/cc 
F1 0.321 
F2 0.303 
F3 0.402 
F4 0.383 
F5 0.364 
F6 0.326 
 
9.3.2 Angle of repose: 
Angle of repose of microspheres was determined by fixed funnel method. Angle repose of 
microspheres was in range of 24º36’ - 33º58’as shown in Table. All formulation showed excellent flow 
ability as represented in term of angle of repose. 
Table 11 
 
 
 
 
 
 
 
 
 
 
 
Formulation Angle of repose 
F1 29º31’ 
F2 27º59’ 
F3 28º47’ 
F4 26º51’ 
F5 30º38’ 
F6 29º54’ 
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9.3.3 Compressibility index: 
It is determined by same tapping method and its range was found to be 9.37-19.81% the 
results was as shown in the table. The compressibility index less than 20% was suggested for all 
formulations excellent flow property. The flow properties of the microspheres have been 
expressed in terms of carr’s index. The carr’s index for all formulation was good and in the 
passable range, which indicates good flow property and suggested that the microspheres could be 
easily handled during the processing.  
Table 12 
Formulation Compressibility index % 
F1 17.59 
F2 19.81 
F3 9.37 
F4 12.46 
F5 14.23 
F6 16.78 
 
9.3.4 Drug entrapment: 
Table 13 
Formulation code Drug entrapment 
F1 55.6 
F2 58.6 
F3 61.2 
F4 64.6 
F5 59.2 
F6 56.7 
 
The drug entrapment efficacies of different formulations were in range of 55.8 -
64.4%w/w.as shown in the table. Drug entrapment efficacy slightly decreased with increase 
HPMC K100 content ratio in microspheres. This is due to the permeation characteristic of 
HPMC K100 that could facilitate diffusion of part of entrapped drug to surrounding medium 
during preparation of floating microspheres. It was observed that the microspheres of all the 
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formulations that the core coat ratio of 1:5 gave highest encapsulation of the drug when 
compared to the ratio of 1:3. The drug loading of felodipine microspheres decreased with 
increase in the concentration of polymer and drug entrapment efficiency of felodipine floating 
microspheres increase with the increase in the concentration of the polymer. 
9.3.5 Particle size analysis: 
Table 14 
 
The particle size was determined by optical microscopy method.It plays an important role 
in floating ability and drug release. If size of microspheres is less than 500µg release rate of drug 
will be high and floating ability will reduce, microspheres ranges between 500µm - 1000µm,the 
floating ability will be more and release rate will be in sustain manner. 
The mean particle size of microspheres was in range 675-897µm.the results were 
tabulated in the table 14.The particle size distribution was almost uniform and narrow in all the 
formulations. It was observed that microspheres with core coat ratio of 1:3 were of less in size, 
when compared to the particle size of 1:5. This may be due to the viscosity of the polymers used. 
 
 
 
 
S.No Formulation code Mean particle size (µm) 
1 F1 723 
2 F2 796 
3 F3 862 
4 F4 897 
5 F5 675 
6 F6 689 
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9.3.6 Percentage yield: 
Table 15 
Formulation code Percentage yield 
F1 64.2 
F2 61.8 
F3 78.3 
F4 72.8 
F5 59.2 
F6 53.7 
 
The percentage yield of different formulation was determined by weighing the 
microspheres after drying. The percentage yield of developed formulations of felodipine floating 
microspheres F1-F6 were found to be in the range of 53.7 -78.3%.  
 
9.3.7 Floating behavior of microspheres: 
Table 16 
 
Microspheres was dispersed in PH 1.2 containing Tween 80 (0.02% w/w) to simulate gastric 
fluid. The F3-F4 Formulations shows best floating ability (96.39-70.23%) in 12 hours. 
Comparatively the remaining formulations showed less floating ability the floating ability of all 
formulations within the range of (45.08 -96.39 %). as showed in Table- 16. The microspheres 
floated for prolonged time over the surface of the dissolution medium without any apparent 
 
Time 
(Hrs.) 
Formulations floating behavior 
F1 F2 F3 F4 F5 F6 
1 84.61 81.35 96.39 93.13 89.23 87.16 
2 78.05 75.74 94.11 91.09 86.73 83.19 
4 71.82 68.94 91.76 88.71 79.84 75.02 
6 66.79 61.96 84.19 80.91 74.20 71.33 
8 62.93 57.71 81.34 78.47 68.51 61.68 
10 53.68 51.87 79.73 76.68 63.17 58.75 
12 51.76 45.08 73.62 70.23 59.06 55.92 
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gelation. It was found that the felodipine microspheres of the formulation F3 showed desirable 
buoyancy and adequate release characteristics.fig 23 
 
 
Fig 23 
 
9.3.8 Scanning Electronic Microscopy: 
Shape and surface characteristics of microspheres were examined by Scanning Electron 
Microscopy. Surface morphology of F3 formulation was examined at an different magnification 
of 40X and 200X, which illustrate the smooth surface of floating  microspheres and small hollow 
cavity present in microspheres which is responsible for floating property. SEM revealed pores on 
the microsphere as well as hollow microsphere interior. The surface morphology internal 
structure of microspheres was determined by SEM as shown in figure 24. From this figure it was 
observed that so many pores are  formed due to the drug release. Some pores may be small on 
big in size due ot the blasting of the drug. 
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Fig 24 
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9.3.9 Dissolution studies: 
Table 17 
 
The drug release data obtained for the formulations from F1 –F6 were tabulated in the 
table 17. The in-vitro release studies of the floating microspheres were studied for all the 
formulations. The cumulative percentage drug released from floating microspheres decreased 
with increase in concentration of polymers PEG 4000, Sodium alginate and HPMC K 100 
respectively. 
Among the definite felodipine floating microspheres formulations, the formulation F3 
was selected as the ideal formulation based on its micrometrics properties, spherical in shape, 
floating behavior, drug loading, drug entrapment efficiency and percentage of drug release over a 
prolonged period over 12hrs (fig 25) for further studies like stability study. 
 
 
 
 
Time 
(Hrs.) 
Percentage drug released 
F1 F2 F3 F4 F5 F6 
0 0 0 0 0 0 0 
1 3.62 3.50 9.82 8.42 9.64 7.23 
2 15.43 12.42 27.28 19.46 23.40 11.39 
3 25.72 24.75 38.03 36.45 30.72 34.22 
4 33.06 31.72 56.07 42.39 36.51 39.76 
5 38.98 37.87 63.41 48.47 44.12 46.31 
6 45.02 43.93 71.51 56.39 49.14 50.13 
7 52.10 50.62 77.60 63.25 57.78 55.76 
8 60.51 56.86 82.51 70.26 65.43 61.42 
10 69.92 61.92 88.53 80.25 76.98 67.31 
12 76.10 68.98 93.72 86.04 81.93 73.97 
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Fig 25 
9.3.10 Stability studies: 
Table 18 
S. No Days % Drug 
retained 5-8ºC 
% Drug r 
retained 27ºC 
% Drug 
retained 42ºC 
1 0 100±00 100±00 100±00 
2 30 94.6±0.015 94.9±0.003 94.7±0.041 
3 45 94.4±0.013 94.7±0.027 94.3±0.036 
4 90 94.2±0.15 94.3±0.012 94.1±0.02 
 
The stability study was carried out for the F3 formulation by exposing it to different 
temperatures 5 -8ºC, 27ºC and 40ºC for 3 months. The sample was analyzed for drug content 
regular intervals.it was found that no remarkable change in the drug content in F3 formulation. 
This indicates that F3 was stable for following temperature. The drug release profile indicated 
that there were no significant changes in the physical as well as chemical characteristics of the 
formulation. Hence it can be concluded from the results that the developed felodipine floating 
microspheres were stable and retained their pharmaceutical property over a period of 3 months. 
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10. CONCLUSION 
Drug absorption in the GIT is a highly variable process, prolonging gastric retention of 
the dosage forms and extends the time of the drug absorption. Floating microspheres are 
prepared with enteric coated polymer (sodium alginate) [successfully by the solvent evaporation 
technique]. Upon incorporation of the hydrophilic polymer, such as HPMC I the shell of 
microspheres, the amount of drug released from microspheres could be enhanced. In-vitro data 
obtained from floating microspheres of felodipine showed excellent flow ability, good buoyancy 
and prolonged drug release. Microspheres of different size and drug content could be obtained by 
varying the formulation variables. Thus, the prepared floating microspheres may prove to the 
potential candidates for multiple unit delivery devices adaptable to any intra-gastric conditions. 
The formulation were evaluated for various micrometrics and characteristic studies. It increases 
the bioavailability of dosage form with prolonged effect, hence improves the patient compliance. 
Mean particle size for all formulations were varied, due to change in drug polymer ratio. True 
density and tapped density values for all formulations were less than of that gastric fluid (1.004 
gm/cm
3
) exhibits good buoyancy. Angle of repose (<40
0
) for all formulations showed excellent 
flow ability. 
 
Drug release pattern was evaluated in 0.1 N HCl (pH 1.2). Release rate of F1, F2, F6 
formulations were found to be slow and incomplete in dissolution medium. Ideal property of 
floating microspheres includes high buoyancy and sufficient release of drug in pH 1.2. it 
necessary to selected appropriate balance between buoyancy and drug release rate from all 
developing floating microspheres.  
 
F3 formulation showed best appropriate balance between buoyancy and drug release rate, 
which can be considered as a best fit for floating microspheres. The design system F3 floats in 
the stomach and prolongs the gastric residence time (GRT). Consequently, it provides sustained 
action. In addition, floating microspheres enabled increase drug absorption rate, as it gradually 
sink in the stomach and arrived at the absorption site. The developed formulation overcomes the 
drawbacks and limitations of sustained release preparations. Therefore multiple unit floating 
systems, i.e., floating microspheres will be possibly beneficial for sustained action. 
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When it is formulated in large scale, the formulation will be economical, due to its ease 
of preparation and buoyancy due to the polymers used in the formulation. Thus, the prepared 
formulation may reduce the frequency of dosing, thereby minimizing occurrence of side effects, 
increase residence time in stomach and increase the effectiveness of the drug. 
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